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DUAL RESONANCE ENERGY TRANSFER 
NUCLEIC ACID PROBES 
CROSS REFERENCE TO RELATED 
APPLICATIONS 
This application is a continuation application of U.S. 
patent application Ser. No. 10/179,730 filed on Jun. 25, 2002, 
now U.S. Pat. No. 7,081,336, which claims the priority ben-
efit of U.S. Provisional Patent Application Ser. No. 60/300, 
672 filed Jun. 25, 2001 and U.S. Provisional Patent Applica-
tion Ser. No. 60/303,258 file by Jul. 3, 2001, the entire 
contents of which are hereby incorporated by reference. 
FIELD OF THE INVENTION 
This invention relates generally to the detection of target 
nucleic acids, such as mRNA. More specifically, the present 
invention relates to a dual molecular beacons approach that 
uses resonance energy transfer to significantly reduce false-
positive signal in detection of target nucleic acids associated 
with disease. 
BACKGROUND OF THE INVENTION 
The ability to monitor and quantify the level of gene 
expression in living cells in real time can provide important 
information concerning the production, temporal and spatial 
processing, localization, and transport of specific mRNA in 
different conditions. This new type of information could 
potentially revolutionize biological studies and may also have 
applications in medical diagnostics and therapeutics. Tech-
nologies currently available for analysis and quantification of 
gene expression such as real-time RT-PCR, Northern blot-
ting, expressed sequence tag (EST), serial analysis of gene 
expression (SAGE) and DNA microarrays are powerful tools 
for in vitro studies; however, they are not capable of quanti-
fying gene expression in living cells. There is a clear need to 
develop molecular probes that can recognize target mRNA in 
living cells with high specificity and instantaneously convert 
such recognition into a measurable signal with a high signal-
to-background ratio. 
2 
gene detection in living cells. In theory, molecular beacons do 
not require a washing step and so should be directly usable in 
living cells (Matsuo, 1998; Sokol et al., 1998). However, 
interaction between molecular beacons and certain intracel-
lular factors can cause fluorescence in the absence of target 
hybridization and lead to false-positive signals (Mitchell, 
2001). Using conventional molecular-beacon-based meth-
ods, the fluorescent signal that results from target hybridiza-
tion cannot be distinguished from any other event that spa-
10 tially separates reporter from quencher, such as probe 
degradation by intracellular nucleases or interaction with 
DNA binding proteins that unwind the hairpin stem structure 
(Li et al., 2000; Dirks et al., 2001; Molenaar, et al., 2001; Fang 
15 
et al., 2000). 
Two linear oligonucleotide probes labeled respectively 
with donor and acceptor fluorophores have been used in 
FRET-based studies of DNA hybridization, DNA secondary 
structure and RNA synthesis (Cardullo et al., 1988; Morrison 
and Stols, 1993; Sixou et al., 1994; Sei-Iida et al., 2000; Tsuji 
20 et al. 2000; Tsuji et al. 2001), however, the sensitivity of 
intracellular gene detection using such probes suffers from 
strong background signal due to unbound probes and cell 
autofluorescence. 
The unique target recognition and signal transduction 
25 capabilities of molecular beacons have led to their application 
in many biochemical and biological assays including quanti-
tative PCR (Vogelstein and Kinzler, 1999; Chen and Mul-
chandani, 2000), protein-DNA interactions (Fang et al., 2000; 
Li et al., 2000), multiplex genetic analysis (Marras et al., 
30 1999; de Baar et al., 2001), and the detection of mRNA in 
living cells (Matsuo 1988; Sokol et al., 1998; Molenaar 
2001 ). However, false-positive signals due to protein-beacon 
interaction and nuclease-induced beacon degradation signifi-
cantly limit the sensitivity of the in vivo applications (Mitch-
35 ell, 2001). The thermodynamic and kinetic properties of 
molecular beacons are dependent on its structure and 
sequence in complex ways (Bonnet et al. 1999; Kuhn et al., 
2002). Moreover, the signal-to-background ratio in target 
detection is dependent not only on design (length and 
40 sequence of the stem and probe) but also on the quality of 
oligonucleotide synthesis and purification (Goddard et al., 
2000; Bonnet et al., 1998) and the assay conditions employed. 
Therefore, there is a strong need in the art to provide 
improved compositions and methods for improved detection 
45 of nucleic acids that exhibit high specificity and sensitivity. 
Molecular beacons are a class of fluorescence-quenched 
nucleic acid probes that can be used in a quantitative fashion; 
these probes fluoresce upon target recognition (i.e., hybrid-
ization) with potential signal enhancement of >200 under 
ideal conditions. Structurally, they are dual-labeled oligo-
nucleotides with a reporter fluorophore at one end and a dark 
quencher at the opposite end (Tyagi and Kramer; 1996). They 
are designed to have a target-specific probe sequence posi-
tioned centrally between two short self-complementary seg-
ments which, in the absence of target, anneal to form a stem-
loop hairpin structure that brings the fluorophore in close 
proximity with the quencher. In this configuration the 
molecular beacon is in the "dark" state (Bernacchi and Mely, 55 
2001 ). The hairpin opens upon hybridization with a comple-
mentary target, physically separating the fluorophore and 
quencher. In this configuration the molecular beacon is in the 
"bright" state. Transition between dark and bright states 
allows for differentiation between bound and unbound probes 60 
and transduces target recognition into a fluorescence signal 
(Matsuo, 1998; Liu et al., 2002). 
Furthermore, there is a need for such compositions and meth-
ods that can be used for detection of genetic transcription in 
vivo. There is a need for such improved compositions and 
methods for observing changes in genetic expression levels in 
50 response to external stimuli, or for the detection of genetic 
abnormalities indicating a potential or actual disease state. 
SUMMARY OF THE INVENTION 
The present invention provides compositions for the detec-
tion of a subject nucleic acid comprising a first nucleic acid 
probe that hybridizes to a first nucleic acid target sequence on 
the subject nucleic acid, forms a stem-loop structure when not 
bound to the first nucleic acid target sequence, and incorpo-
rates a resonance energy transfer donor moiety. This embodi-
ment of the invention further provides a second nucleic acid 
probe that hybridizes to a second nucleic acid target sequence 
on the subject nucleic acid, forms a stem-loop structure when 
not bound to the second nucleic acid target sequence, and 
incorporates a resonance energy transfer acceptor moiety. 
The invention provides that the first nucleic acid target 
sequence and the second nucleic acid target sequence are 
Linear fluorescent probes, as are used in fluorescence in-
situ hybridization (FISH) (Femino et al., 1998), are "bright" 
in both the bound and unbound state. To detect positive signal 65 
after hybridization, unbound probe must be removed by 
washing, which prevents the application of this method to 
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separated by a number of nucleotides on the subject nucleic 
acid such that a resonance energy transfer signal from inter-
action between the donor moiety of the first nucleic acid 
probe and the acceptor moiety of the second nucleic acid 
probe can be detected to determine hybridization of both the 
first nucleic acid probe and the second nucleic acid probe to 
the subject nucleic acid. 
Therefore, according to the present invention, alternative 
compositions and methods are provided for the detection of 
subject nucleic acid sequences of interest in a sample. In 10 
particularly preferred embodiments, fluorescent or lumines-
cent resonance energy transfer moieties are provided on hair-
pin stem-loop molecular beacon probes that hybridize suffi-
ciently near each other on a subject nucleic acid, e.g. mRNA, 
to generate an observable interaction. The invention thereby 15 
provides signal of energy transfer for rapid, specific and sen-
sitive hybridization detection that can be advantageously 
used in vivo. The probes are useful in methods of detection of 
target nucleic acid hybridization and the identification of 
genetic expression and the presence of genetic variations 20 
associated with disease, such as cancer. 
Accordingly, it is an object of the present invention to 
provide improved compositions and methods of use for more 
sensitive, specific or rapid nucleic acid detection. 
It is a further object of the present invention to provide 25 
improved methods for the detection of gene expression asso-
ciated with a response to external stimuli, e.g. a therapeutic 
drug candidate. 
It is a further object of the present invention to provide 
improved methods for the detection of gene expression, 30 
including genetic expression associated with a disease state. 
It is another object of the present invention to provide for 
the use of such compositions and method in vivo. 
These and other objects, features and advantages of the 
present invention will become apparent after a review of the 35 
following detailed description of the disclosed embodiments 
and the appended claims. 
BRIEF DESCRIPTION OF THE FIGURES 
4 
The error bars display the minimum and maximum ratios 
calculated for dual FRET molecular beacons separated by 3, 
4, 5, or 6 bases. 
FIG. 5 shows emission spectra for dual FRET molecular 
beacons with a Fam-Texas Red FRET pair. The samples 
described in the figure were excited at a wavelength of 475 
nm. 
FIG. 6 shows normalized peak emission of the acceptor 
due to FRET for molecular beacon pairs with a Fam donor 
and a Cy3, ROX, or Texas Red acceptor. All the intensities 
were normalized relative to the peak intensity of the Fam-
labeled donor beacon bound to target. 
FIG. 7 shows the effect of spacing between donor and 
acceptor beacons on the fluorescence emission of acceptor 
dye for dual FRET molecular beacons with a Fam donor and 
a Texas Red acceptor. Four different targets were tested, sepa-
rating the donor and acceptor beacons by 3, 4, 5, or 6 bases. 
FIGS. Sa and Sb show time resolved emission spectra 
obtained in a two-probe detection assay using Terbium che-
late as a donor and (Sa) Cy3 as an acceptor and (Sb) ROX as 
an acceptor. All samples were excited at a wavelength of325 
nm. 
FIG. 9 shows time resolved emission spectra generated by 
a two-probe detection assay utilizing a Europium-labeled 
oligonucleotide as a donor probe and a Cy5-labeled oligo-
nucleotide as an acceptor probe. 
FIGS. lOa and lOb show one-photon (lOa) and two-photon 
(lOb) excitation spectra of 6-Fam labeled and Cy3 labeled 
oligonucleotides. 
FIGS. lla and llb shows alternative molecular beacon 
designs. FIG. lla shows Conventional molecular beacons 
have stem sequences that are independent of the target 
sequence. FIG. llb shows shared-stem molecular beacons 
are designed such that one arm of the stem participates in both 
hairpin formation and target hybridization. 
FIGS. 12a and 12b show examples of the design constraint 
of shared-stem molecular beacons with certain stem/probe 
combinations. FIG. 12a-shows the design of a molecular 
beacon with a probe length of 19 bases and a stem length of 6 
40 bases inadvertently resulted in additional bases participating 
in stem formation (circles). FIG. 12a shows the design of a 
molecular beacon with a probe length of 18 bases and a stem 
length of 4 bases inadvertently resulted in an additional base 
FIG. 1 shows hybridization of the donor and acceptor 
molecular beacons to adjacent regions on the same mRNA 
target results in FRET. By detecting FRET, fluorescence sig-
nals due to probe/target binding can be distinguished from 
that due to beacon degradation and non-specific interactions. 45 
In the figure, letters Q, D and A represent respectively 
quencher, donor dye and acceptor dye molecules. 
FIG. 2 shows a schematic of the assay system with 4-base 
spacing between donor and acceptor molecular beacons when 
hybridized to the synthetic target. In this example both bea-
cons have a probe length of 19 bases and a stem length of 5 
bases. The underscores indicate the 38-base sequence of the 
target complementary to the beacons. Note that for each bea-
con one arm of the stem is part of the probe sequence so that 
the movement of the dye molecules is restricted after hybrid-
ization. 
FIG. 3 shows typical emission spectra of dual FRET 
molecular beacons. Three signal-to-background ratios are 
defined: S:BdA-fB represents the enhancement in fluorescence 
of a conventional molecular beacon in the presence of target. 
S:BaMB indicates the increase in fluorescence resulting from 
the sensitized emission of the acceptor. S:Ndeg is the ratio of 
the signal from sensitized emission of the acceptor to the 
false-positive signal. 
FIGS. 4a-4c show signal-to-noise ratios for dual FRET 
molecular beacons with (4a) a Fam-Cy3 FRET pair, (4b) a 
Fam-ROX FRET pair and (4c) a Fam-Texas Red FRET pair. 
participating in target hybridization (circle). 
FIG. 13 shows a comparison of the milting temperature of 
shared-stem and conventional molecular beacons as deter-
mined by the initial concentrations of probe and target. By 
fitting the data with a straight line, changes in enthalpy (slope 
of the fitted line) and entropy (y-intercept) characterizing the 
50 phase transition between bound-to-target and stem-loop con-
formations of a molecular beacon were obtained. 
FIG. 14 shows determination of the changes in enthalpy 
(slope of the fitted line) and entropy (y-intercept) character-
izing the phase transition between bound-to-target and stem-
55 loop conformations for conventional molecular beacons. 
Similar trend was found for shared-stem molecular beacons. 
FIGS. 15a and 15b show determination of the changes in 
enthalpy (slope of the fitted line) and entropy (y-intercept) 
characterizing the phase transition between bound-to-target 
60 and stem-loop conformations for FIG. 15a shared-stem and 
FIG. 15b conventional molecular beacons interacting with 
wild-type and mutant targets. 
FIG. 16 shows a comparison of melting temperatures as a 
function of stem length for conventional and hared-stem 
65 molecular beacons in the presence of wild-type target. 
FIGS. 17a and 17b show melting behavior of conventional 
and shared-stem molecular beacons with a 19-base probe and 
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a 5-base stem. FIG. 17a shows melting curves for conven-
tional and shared-stem molecular beacons in the presence of 
wild-type (solid line) and mutant (dashed line) target. FIG. 
17 b shows the difference in the fraction of conventional or 
shared-stem molecular beacons bound to wild-type and 
mutant targets. 
FIG. 18 shows the difference in the fraction of beacons 
bound to wild-type and mutant targets for shared-stem 
molecular beacons with stem lengths of 4, 5, and 6 bases. The 
same trend is true for conventional molecular beacons. 
FIGS. 19a and 19b show a comparison between conven-
tional and shared-stem molecular beacons on FIG. l9a the 
on-rate of hybridization with target and FIG. l9b the disso-
ciation constant without target (i.e., the transition between 
stem-loop hairpin and random-coiled beacons) for molecular 
beacons with a 19-base probe length and various stem 
lengths. 
DETAILED DESCRIPTION OF THE INVENTION 
The present invention may be understood more readily by 
reference to the following detailed description of the pre-
ferred embodiments of the invention and the Examples 
included therein. Before the present compounds, composi-
tions, and methods are disclosed and described, it is to be 
understood that this invention is not limited to any specific 
nucleic acid probes, specific nucleic acid targets, specific cell 
types, specific conditions, or specific methods, etc., as such 
may, of course, vary, and the numerous modifications and 
variations therein will be apparent to those skilled in the art. It 
6 
acceptor moiety, wherein the first nucleic acid target 
sequence and the second nucleic acid target sequence are 
separated by a number of nucleotides on the subject nucleic 
acid such that a luminescence resonance energy transfer sig-
nal from interaction between the lanthanide chelate donor 
moiety of the first nucleic acid probe and the acceptor moiety 
of the second nucleic acid probe can be detected to determine 
hybridization of both the first nucleic acid probe and the 
second nucleic acid probe to the subject nucleic acid. In 
10 certain embodiments of this invention, the first nucleic acid 
probe or second nucleic acid probe is linear or randomly 
coiled when not hybridized to the first or second nucleic acid 
target sequences, respectively. In other embodiments of this 
invention, the first nucleic acid probe or second nucleic acid 
15 probe forms a stem-loop structure when not hybridized to the 
first or second nucleic acid target sequences, respectively. 
In certain preferred embodiments of the invention, the first 
nucleic acid probe further incorporates a quencher moiety, 
such that an interaction between the donor moiety of the first 
20 nucleic acid probe and the quencher moiety can be detected to 
differentiate between the first nucleic acid probe in the stem-
loop structure and non-stem-loop structure. Similarly, in 
other embodiments, the second nucleic acid probe further 
incorporates a quencher moiety, such that an interaction 
25 between the acceptor moiety of the second nucleic acid probe 
and the quencher moiety can be detected to differentiate 
between the second nucleic acid probe in the stem-loop struc-
ture and non-stem-loop structure. In embodiments utilizing a 
quencher moiety on a nucleic acid probe, the invention pro-
30 vides that the quencher moiety can be selected from, for 
example, dabcyl quencher, black hole quencher or Iowa 
Black quencher or other moieties well-known in the art to 
change the resonance energy transfer wavelength emission of 
is also to be understood that the terminology used herein is for 
the purpose of describing particular embodiments only and is 
not intended to be limiting. As used in the specification and in 
the claims, "a" or "an" can mean one or more, depending 
upon the context in which it is used. Thus, for example, 35 
reference to "a nucleic acid pro be" can mean that one or more 
than one nucleic acid probe can be utilized. 
an unquenched donor or acceptor moiety. 
In certain other embodiments, the first nucleic acid probe 
further incorporates a resonance energy transfer moiety pair, 
such that a resonance energy transfer signal from interaction 
between the donor moiety and the acceptor moiety on the first 
nucleic acid probe can be detected to differentiate between 
In accordance with the purpose(s) of this invention, as 
embodied and broadly described herein, this invention, in one 
aspect, provides a composition for the detection of a subject 
nucleic acid comprising, a first nucleic acid probe that hybrid-
izes to a first nucleic acid target sequence on the subject 
nucleic acid, forms a stem-loop structure when not bound to 
the first nucleic acid target sequence, and incorporates a reso-
nance energy transfer donor moiety. This embodiment of the 
invention further provides a second nucleic acid probe that 
hybridizes to a second nucleic acid target sequence on the 
subject nucleic acid, forms a stem-loop structure when not 
bound to the second nucleic acid target sequence, and incor-
porates a resonance energy transfer acceptor moiety. The 
invention provides that the first nucleic acid target sequence 
and the second nucleic acid target sequence are separated by 
a number of nucleotides on the subject nucleic acid such that 
a resonance energy transfer signal from interaction between 
the donor moiety of the first nucleic acid probe and the accep-
tor moiety of the second nucleic acid probe can be detected to 
determine hybridization of both the first nucleic acid probe 
and the second nucleic acid probe to the subject nucleic acid. 
Preferably, the resonance energy transfer signal is a florescent 
or luminescent signal. 
40 the first nucleic acid probe in the stem-loop structure and 
non-stem-loop structure. Similarly, other embodiments pro-
vide that the second nucleic acid probe further incorporates a 
resonance energy transfer moiety pair, such that a resonance 
energy transfer signal from interaction between the donor 
45 moiety and the acceptor moiety on the second nucleic acid 
probe can be detected to differentiate between the second 
nucleic acid probe in the stem-loop structure and non-stem-
loop structure. 
In various embodiments, the first nucleic acid target and the 
50 second nucleic acid target are separated by 1 to 20 nucle-
otides, or separated by 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 
or 15 nucleotides. As discussed below, the preferred number 
of separating nucleotides will vary depending upon the reso-
nance energy transfer source used, and can be routinely deter-
55 mined by one of skill in the art in view of the present disclo-
sure. 
In preferred embodiments, the resonance energy signals 
are due to fluorescence resonance energy transfer (FRET) or 
luminescence resonance energy transfer (LRET). In embodi-
60 ments wherein the resonance energy transfer signal is due to 
fluorescence resonance energy transfer, the donor moiety can 
be for example a 6-Fam fluorophore. In embodiments 
wherein the resonance energy transfer signal is due to fluo-
In an alternative embodiment, the invention provides a first 
nucleic acid probe that hybridizes to a first nucleic acid target 
sequence on the subject nucleic acid, and incorporates a lumi-
nescence resonance energy transfer lanthanide chelate donor 
moiety; and second nucleic acid probe that hybridizes to a 65 
second nucleic acid target sequence on the subject nucleic 
acid, and incorporates an organic resonance energy transfer 
rescence resonance energy transfer, the acceptor moieties can 
be Cy-3, ROX or Texas Red. Additional examples of FRET 
donor and acceptor moieties useful in the present invention 
are provided below. 
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In other embodiments, the resonance energy transfer signal 
8 
Resonance energy transfer detections of the present invention 
can be performed with the assistance of single- or multiple-
photon microscopy, time-resolved fluorescence microscopy 
or fluorescence endoscopy, as detailed below. 
The invention further provides kits for the detection of a 
subject nucleic acid comprising the nucleic acid probe com-
positions described herein, necessary reagents and instruc-
tions for practicing the methods of detection. Such alternative 
compositions, methods and kits therefor are described in 
is due to luminescence resonance energy transfer (LRET) and 
the donor moiety is a lanthanide chelate. In some preferred 
embodiments where the resonance energy signal is due to 
LRET, the donor moiety can be Europium or Terbium. Fur-
thermore, in some embodiments where the resonance energy 
signal is due to LRET, the donor moiety can be a lanthanide 
chelate such as DTPA-cytosine, DTPA-cs124, BCPDA, 
BHHCT, Isocyanato-EDTA, Quantum Dye, or W1024 and 
the acceptor moiety can be Cy-3, ROX or Texas Red. In some 
embodiments, due to the range of effective resonance energy 
transfer of the lanthanide chelate, multiple acceptor moieties 
may be employed. The donor moiety can be a lanthanide 
chelate and the acceptor moiety can be a phycobiliprotein. In 
certain embodiments, the phycobiliprotein is Red Phyco- 15 
erythrin (RPE), Blue Phycoerythrin (BPE), or Allophycocya-
nin (APC). Additional examples ofLRET donor and acceptor 
moieties useful in the present invention are provided below. 
10 more detail by way of the examples, and still others will be 
apparent to one of skill in the art in view of the present 
disclosure. 
In certain embodiments, the invention provides that the 
first or second nucleic acid probes each comprise from 5 to 50 20 
nucleotides, !Oto 40 nucleotides, or 15, 16, 17, 18, 19, 20, 21, 
22, 23, 24, 25, 26, 27, 28, 29 or 30 nucleotides. In other 
preferred embodiments, the nucleic acid probes comprise a 
2'-0-methyl nucleotide backbone, among many alternative or 
synthetic nucleotides, described below. The invention further 25 
provides that one end of the first and/or the second nucleic 
acid probes participates in both stem-loop formation and 
hybridization to the target nucleic acid. Such embodiments 
are referred to herein as a shared-stem molecular beacon, or 
probe, herein, and are described in more detail below, par- 30 
ticularly in Example 2. 
In additional embodiments, the invention provides meth-
ods for detecting a subject nucleic acid, comprising combin-
ing the composition described herein with a sample suspected 
of containing a subject nucleic acid, and detecting hybridiza- 35 
tion by differential resonance energy transfer signal to deter-
mine the presence or absence, and/or the expression level of 
the subject nucleic acid in the sample in vitro or in vivo. In 
some preferred embodiments, the methods can be performed 
in vivo. Therefore, in a preferred embodiment of this method, 40 
the sample contains a living cell. The invention provides that 
the methods may be performed with samples comprising 
living tissues and cells that are taken out of the body, or that 
remain in situ. 
One embodiment of the present invention provides com-
positions and methods that measure a resonance energy trans-
fer, for example, a fluorescent signal due to FRET or LRET as 
a result of direct interaction between two molecular beacons 
when hybridized to the same target nucleic acid of interest. 
This method can dramatically reduce false-positive signals in 
gene detection and quantification in living cells. As shown in 
FIG. 1 and alternatively in FIG. 11, this approach utilizes a 
pair of molecular beacons, one with a donor fluorophore and 
a second with an acceptor fluorophore. Probe sequences are 
chosen such that the molecular beacons hybridize adjacent to 
each other on a single nucleic acid target in a way that posi-
tions their respective fluorophores in optimal configuration 
for FRET (Mergny et al., 1994; Sixou et al. 1994). Emission 
from the acceptor fluorophore serves as a positive signal in the 
FRET based detection assay. 
If acceptor and donor fluorophores are well matched, exci-
tation of the donor can be achieved at a wavelength that has 
little or no capacity to excite the acceptor; excitation of the 
acceptor will therefore only occur if both molecular beacons 
are hybridized to the same target nucleic acid and FRET 
occurs. Molecular beacons that are degraded or open due to 
protein interactions will result in the presence of unquenched 
fluorophore, however, fluorescence emitted from these spe-
cies is different in character from the signal obtained from 
donor/acceptor FRET pair, making background and true posi-
tive signal more readily differentiated. Thus, by detecting 
FRET instead of direct single-molecule fluorescence, nucleic 
acid probe/target binding events can be distinguished from 
false-positives. 
In contrast to prior labeling of two linear oligonucleotide 
probes with donor and acceptor fluorophores, the stem-loop 
45 hairpin structure of molecular beacons offers further reduc-
tion in background fluorescence as well as enhanced speci-
ficity, which is helpful particularly when detection of allelic 
variants or point mutations is desired (Bonnet et al., 1999; 
The methods of the present invention further include detec-
tion of changes in the levels of expression of a nucleic acid 
target, or in RNA transcript, such that alterations of gene 
expression can be monitored as a result of the dose-dependent 
cellular response to external stimuli, such as drug molecules, 
hormones, growth factors, temperature, shear flow, or micro- 50 
gravity, for example. The invention further provides that the 
compositions can be used to visualize, i.e., through fluores-
cence or luminescence, the location and relative amount of 
gene expression in tissues and cells. 
In diagnostic or prognostic detection methods the subject 55 
nucleic acid can comprise a genetic point mutation, deletion, 
or insertion relative to a naturally occurring or control nucleic 
acid. Such screening methods can permit the detection of the 
subject nucleic acid indicating the presence of a genetically 
associated disease, such as certain cancers, in the sample. 60 
There are many well-known examples of genetic mutations 
already in the art that are indicative of a disease state. The 
methods include the detection of nucleic acids comprising 
K-ras, survivin, p53, p16, DPC4, or BRCA2. Furthermore, 
the methods can be used to detect the amount of a subject 65 
nucleic acid being produced by an organism for purposes 
other than diagnosis or prognosis of a disease or condition. 
Tsourkas et al., 2002a). 
Further benefit from another embodiment of the dual 
energy transfer molecular beacons and method of the present 
invention can be achieved by employing an oligonucleotide 
probe with a lanthanide chelate as the donor and a molecular 
beacon with a traditional organic fluorophore as the acceptor 
(reporter) moiety. In contrast to organic fluorophores that 
have a fluorescence lifetime of -10 ns, lanthanide chelates 
can have emission lifetimes greater than 1 ms (Sueda et al; 
2000; Evangelista et al., 1988). The mechanism that is 
responsible for the long lifetime emission oflanthanide che-
lates is complex and involves energy transfer from the triplet 
state of the aromatic ligand. Specifically, upon excitation the 
ligand is excited to its singlet state and then undergoes an 
intersystem transition to its triplet state, whereas the energy is 
either quenched by water molecules or transferred to the 
lanthanide ion. Fluorescence is then emitted from the lan-
thanide ion as it returns to the ground state (Lemmetyinen et 
al., 2000). Since such fluorescence emission does not result 
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from a singlet-to-singlet transition, the use oflanthanide che-
lates as a donor results in luminescent resonance energy trans-
10 
such an embodiment, the quencher moiety on the first pro be is 
replaced with a reciprocating moiety to form a resonance 
energy transfer moiety pair, and the differential in resonance 
energy transfer is detectable between the hairpin stem-loop 
structure and a non-stem-loop structure. Alternatively, the 
quencher moiety on the second probe is replaced with a 
reciprocating moiety to form a resonance energy transfer 
moiety pair, and the differential in resonance energy transfer 
is detectable between the hairpin stem-loop structure and a 
fer (LRET). Therefore, by using pulse excitation and time-
gating techniques, it is possible to selectively record emission 
after the background fluorescence from organic dyes, scatter-
ing, and autofluorescence has decayed (Yuan et al, 1998; 
Lopez et al, 1993). The only signals remaining in this long-
time domain are the emission from the lanthanide chelate and 
from acceptor fluorophores that have participated in LRET. In 
this case the narrow emission peaks of a lanthanide chelate 
render the background fluorescence close to zero at certain 
wavelengths, leading to extremely large signal-to-back-
ground ratio. The donor probe in a LRET pair can be a simple 
linear probe, i.e., neither quencher nor hairpin structure are 
necessary. 
10 non-stem-loop structure. In such embodiments of the present 
invention, a third resonance energy transfer moiety pair forms 
by the dual probes, a donor moiety on the first probe, and an 
acceptor moiety on the second probe, such that the resonance 
energy transfer signal due to the interaction of donor and 
15 acceptor may be measured to assess the progress of the 
hybridization reaction of both probes on the subject nucleic 
acid. 
Furthermore, the invention provides a design variant for 
molecular beacons where one arm of the stem participates in 
both hairpin formation and target hybridization, referred to 
herein as "shared-stem" molecular beacons. In contrast, con-
ventional molecular beacons are designed such that the loop 20 
sequence is complementary to the target while the stem 
sequences are self-complementary but unrelated to the target 
sequence. This new design offers certain advantages over 
conventional molecular beacon design, especially in two-
probe fluorescence resonance energy transfer (FRET) assays 25 
(Cardullo et al., 1998; Sei-Iida et al., 2000; Tsuji et al., 2000; 
Tsuji et al., 2001; Tsourkas and Bao 2001). The invention 
provides the thermodynamic and kinetic properties of both 
shared-stem and conventional molecular beacons and makes 
a systematic comparison between them. In particular, the 30 
present description quantifies the changes in enthalpy and 
entropy upon the formation of probe/target duplexes as deter-
mined by the probe and stem lengths. Further provided herein 
is a study of the melting behavior, specificity, and hybridiza-
tion on-rate depend on the stem length of molecular beacons, 35 
such that one of skill in the art may make and use a variety of 
embodiments to suit the specific purposes of each situation. 
The nucleic acid probes of the invention utilize the prin-
ciple of resonance energy transfer between a donor moiety 
and an acceptor moiety. In a preferred embodiment, the reso- 40 
nance energy transfer is fluorescence resonance energy trans-
fer (FRET), in which the first and second probes are labeled 
with donor and acceptor moieties, respectively, wherein the 
donor moiety is a fluorophore and the acceptor moiety may be 
a fluorophore, such that fluorescent energy emitted by the 45 
donor moiety is absorbed by the acceptor moiety when both 
probes are hybridized to the first and second target sequences 
respectively on the same nucleic acid subject. In one embodi-
ment of the present invention, the acceptor moiety is a fluo-
rophore that releases the energy absorbed from the donor at a 50 
different wavelength; the emissions of the acceptor may then 
be measured to assess the progress of the hybridization reac-
tion. 
In another embodiment, the present invention provides that 
one of the nucleic acid probes is linear (non-stem-loop) and 
the probes are separately labeled with lanthanide chelator 
donor and organic acceptor moieties, such that resonance 
energy transfer will occur when the nucleic acid probes are 
hybridized. In yet another embodiment, the invention uses a 
pair of such linear primers, one labeled with a lanthanide 
donor and another with an organic acceptor moiety, respec-
tively. 
One aspect of the invention pertains to nucleic acids suffi-
cient for use as hybridization probes for the identification of 
a target nucleic acid (e.g., DNA or mRNA). As used herein, 
the term "nucleic acid" is intended to include DNA molecules 
(e.g., cDNA or genomic DNA) and RNA molecules (e.g., 
mRNA) and analogs of the DNA or RNA generated using 
nucleotide analogs. As referred to herein, nucleic acids that 
are "complementary" can be perfectly or imperfectly comple-
mentary, as long as the desired property resulting from the 
complementarity is not lost, e.g., ability to hybridize. 
The nucleic acids of the present invention may be substan-
tially isolated or alternatively unpurified. An "isolated" or 
"purified" nucleic acid is one that is substantially separated 
from other nucleic acid molecules that are present in the 
natural source of the nucleic acid. Preferably, an "isolated" 
nucleic acid is substantially free of sequences that naturally 
flank the nucleic acid (i.e., sequences located at the 5' and 3' 
ends of the nucleic acid) in the genomic DNA of the organism 
from which the nucleic acid is derived. Moreover, an "iso-
lated" nucleic acid molecule can be substantially free of other 
cellular material, or culture medium when produced by 
recombinant techniques, or chemical precursors or other 
chemicals when chemically synthesized. (see, Sambrook et 
al. 1989, Molecular Cloning: A Laboratory Manual. 2nd, ed., 
Cold Spring Harbor Laboratory, Cold Spring Harbor Labo-
ratory Press, Cold Spring Harbor, N.Y.). 
The probe typically comprises substantially purified 
nucleic acid. The nucleic acid probe typically comprises a In a preferred embodiment, the pro be is a hairpin stem-loop 
structure (often referred to in the art as a molecular beacon) 
that contains either a donor or acceptor moiety and optionally 
a quencher moiety, such that the quencher moiety reduces the 
fluorescence of the donor or acceptor when the probe is in the 
stem-loop structure (i.e., not hybridized). When the probe is 
hybridized to the target nucleic acid in this embodiment, its 
conformation changes, eliminating the quenching effect, and 
the resulting fluorescence of the donor or acceptor moiety 
may be detected. 
55 region of nucleotide sequence that hybridizes to at least about 
5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 
23, 24, 25, 26, 27, 28, 29, 30, 35, 40, 45 or 50 consecutive 
nucleotides of a target nucleic acid. The target nucleic acid 
can be a sense strand of one of the target nucleic acid 
60 sequences, an anti-sense sequence, or naturally occurring 
mutants thereof. Preferably, the nucleic acid target is an 
mRNA. 
In an alternative embodiment, the present invention pro-
vides a nucleic acid probe that forms a hairpin stem-loop 65 
structure in which resonance energy transfer will decrease 
when the probe is hybridized with the target nucleic acid. In 
Probes based on the nucleotide sequences can be used to 
detect or amplify transcripts or genomic sequences encoding 
the same or homologous proteins. In other embodiments, the 
probe further comprises a label group attached thereto, e.g., 
the label group can be a radioisotope, an enzyme, or an 
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enzyme co-factor. Such probes can be used as a part of a 
genomic marker test kit for identifying cells which express a 
particular protein, such as by measuring a level of the protein-
encoding nucleic acid in a sample of cells, e.g., detecting the 
target nucleic acid mRNA levels or determining whether the 
gene encoding the mRNA has been mutated or deleted. 
In an additional preferred embodiment, an isolated nucleic 
acid molecule of the invention comprises a nucleic acid probe 
sequence that hybridizes, e.g., hybridizes under stringent 
conditions, to a target nucleotide sequence of interest. These 
hybridization conditions include washing with a solution 
having a salt concentration of about 0.02 molar at pH 7 at 
about 60° C. As used herein, the term "hybridizes under 
stringent conditions" is intended to describe conditions for 
hybridization and washing under which nucleotide sequences 
at least 60% homologous to each other typically remain 
hybridized to each other. Preferably, the conditions are such 
that sequences at least about 65%, more preferably at least 
about 70%, and even more preferably at least about 75% or 
more homologous to each other typically remain hybridized 
to each other. Such stringent conditions are known to those 
skilled in the art and can be found in Current Protocols in 
Molecular Biology, John Wiley & Sons, N.Y. (1989) 6.3.1-
6.3.6. A preferred, non-limiting example of stringent hybrid-
ization conditions are hybridization in 6x sodium chloride/ 
sodium citrate (SSC) at about 45° C., followed by one or more 
washes in0.2xSSC, 0.1 % SDS at 50-65° C.As used herein, a 
"naturally-occurring" nucleic acid molecule refers to an RNA 
or DNA molecule having a nucleotide sequence that occurs in 
nature (e.g., encodes a natural protein). 
The nucleic acid probes of the invention can be DNA or 
RNA or chimeric mixtures or derivatives or modified versions 
thereof, so long as it is still capable of hybridizing to the 
desired target nucleic acid. In addition to being labeled with a 
resonance energy transfer moiety, the nucleic acid sequence 
can be modified at the base moiety, sugar moiety, or phos-
phate backbone, and may include other appending groups or 
labels, so long as it is still capable of priming the desired 
amplification reaction, or functioning as a blocking oligo-
nucleotide, as the case may be. 
For example, a nucleic acid probe of the present invention 
can be chemically synthesized using naturally occurring 
nucleotides or variously modified nucleotides designed to 
increase the biological stability of the molecules or to 
increase the physical stability of the duplex formed between 
the complimentary nucleic acids, e.g., phosphorothioate 
derivatives and acridine substituted nucleotides can be used. 
12 
ester, uracil-5-oxyacetic acid (v), 5-methyl-2-thiouracil, 
3-(3-amino-3-N-2-carboxypropyl) uracil, (acp3)w, and 2,6-
diaminopurine. 
In another embodiment, the nucleic acid probe of the 
present invention comprises at least one modified sugar moi-
ety selected from the group including but not limited to ara-
binose, 2-fluoroarabinose, xylulose, and hexose. In yet 
another embodiment, the nucleic acid probe of the present 
invention comprises at least one modified phosphate back-
10 bone selected from the group consisting of a phosphorothio-
ate, a phosphorodithioate, a phosphoramidothioate, a phos-
phoramidate, a phosphordiamidate, a methylphosphonate, an 
alkyl phosphotriester, and a formacetal or analog thereof. As 
stated above, a preferred example of a modified nucleotide 
15 which can be used to generate the nucleic acid probes is a 
2'-0-methyl nucleotide. 
Nucleic acid probes of the invention may be synthesized by 
standard methods known in the art, e.g. by use of an auto-
mated DNA synthesizer (such as are commercially available 
20 from Biosearch, Applied Biosystems, etc.). As examples, 
phosphorothioate oligonucleotides may be synthesized by 
the method of Stein et al. (1988, Nucl. Acids Res. 16:3209), 
methylphosphonate oligonucleotides can be prepared by use 
of controlled pore glass polymer supports (Sarin et al., 1988, 
25 Proc. Natl.Acad. Sci. U.S.A. 85:7448-7451), etc. 
Once the desired oligonucleotide is synthesized, it is 
cleaved from the solid support on which it was synthesized 
and treated, by methods known in the art, to remove any 
protecting groups present. The oligonucleotide may then be 
30 purified by any method known in the art, including extraction 
and gel purification. The concentration and purity of the oli-
gonucleotide may be determined by examining oligonucle-
otide that has been separated on an acrylamide gel, or by 
measuring the optical density at 260 nm in a spectrophotom-
35 eter. 
Nucleic acid probes of the invention may be labeled with 
donor and acceptor moieties during chemical synthesis or the 
label may be attached after synthesis by methods known in 
the art. In a specific embodiment, the following donor and 
40 acceptor pairs are used: a luminescent lanthanide chelate, 
e.g., terbium chelate or lanthanide chelate, is used as the 
donor, and an organic dye such as fluorescein, rhodamine or 
CY-5, is used as the acceptor. Preferably, terbium is used as a 
donor and fluorescein or rhodamine as an acceptor, or 
45 europium is used as a donor and CY-5 as an acceptor. In 
another specific embodiment, the donor is fluorescent, e.g. 
fluorescein, rhodamine or CY-5, and the acceptor is lumines-
cent, e.g. a lanthanide chelate. In yet another embodiment, the 
energy donor is luminescent, e.g., a lanthanide chelate, and 
A preferred example of a class of modified nucleotides which 
can be used to generate the nucleic acid probes is a 2'-0-
methyl nucleotide. Additional examples of modified nucle-
otides which can be used to generate the nucleic acid probes 
include for example 5-fluorouracil, 5-bromouracil, 5-chlor-
ouracil, 5-iodouracil, hypoxanthine, xanthine, 4-acetylcy-
tosine, 5-( carboxyhydroxylmethyl) uracil, 5-carboxymethy-
laminomethyl-2-thiouridine, 
5-carboxymethylaminomethyluracil, dihydrouracil, beta-D-
galactosylqueosine, inosine, N6-isopentenyladenine, 1-me-
thylguanine, 1-methylinosine, 2,2-dimethylguanine, 2-me-
thyladenine, 2-methylguanine, 3-methylcytosine, 
5-methylcytosine, N6-adenine, 7-methylguanine, 5-methy- 60 
laminomethyluracil, 5-methoxyaminomethy 1-2-thiouracil, 
beta-D-mannosylqueosine, 5'-methoxycarboxymethyluracil, 
5-methoxyuracil, 2-methylthio-N-6-isopentenyladenine, 
uracil-
50 the energy acceptor may be non-fluorescent. 
55 
In another specific embodiment, the donor moiety is a 
fluorophore. In another specific embodiment, both donor and 
acceptor moieties are fluorophores. Suitable moieties that can 
be selected as donor or acceptors in FRET pairs are set below: 
4-acetamido-4'-isothiocyanatostilbene-2,2'Disulfonic 
Acid Acridine and Derivatives: 
acridine 
acridine isothiocyanate 
5-(2'-aminoethyl)aminonaphthalene-l-sulfonic 
(ED ANS) 
4-amino-N-[3-viny lsulfony !)phenyl ]naphthalimide-3, 
5disulfonate (Lucifer Yellow VS) 
N-( 4-anilino-1-naphthyl)maleimide 
Anthranilamide 
acid 
5-oxyacetic acid (v), wybutoxosine, pseudouracil, que- 65 
osine, 2-thiocytosine, 5-methyl-2-thiouracil, 2-thiouracil, 
4-thiouracil, 5-methyluracil, uracil-5-oxyacetic acid methyl- Brilliant Yellow 
US 7,399,591 B2 
coumarin and derivatives: 
coumann 
13 
7-amino-4-methylcoumarin (AMC, Coumarin 120) 
7-amino-4-trifluoromethy lcoumarin ( Coumarin 151) 
cyanosine 
4'-6-diaminidino-2-phenylindole (DAPI) 
5' ,5 "-dibromopyrogallol-sulfonephthalein (Bromopyro-
gallol Red) 
7-diethy lamino-3-( 4'-isothiocyanatopheny1)-4-methyl-
coumann 
diethylenetriamine pentaacetate 
4-( 4 '-diisothiocyanatodihydro-stilbene-2,2'-disulfonic 
acid 
4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid 
5-[ dimethylamino ]naphthalene-1-sulfonyl chloride (DNS, 
dansyl chloride) 
4-( 4'-dimethylaminophenylazo )benzoic acid (DABCYL) 
4-dimethy laminopheny lazophenyl-4 '-isothiocyanate 
(DAB ITC) 
eosin and derivatives: 
eosm 
eosin isothiocyanate 
erythrosin and derivatives: 
erythrosin B 
erythrosin isothiocyanate 
ethidium 
fluorescein and derivatives: 
5-carboxyfluorescein (FAM) 
5-( 4,6-dichlorotriazin-2-yl)aminofluorescein (DTAF) 
2'7'-dimethoxy-4'5'-dichloro-6-carboxyfluorescein (JOE) 
fluorescein 
fluorescein isothiocyanate 
QFITC (XRITC) 
fluorescamine 
IR144 
IR1446 
Malachite Green isothiocyanate 
4-methy lumbelliferone 
ortho cresolphthalein 
nitrotyrosine 
pararosaniline 
Phenol Red 
B-phycoerythrin 
o-phthaldialdehyde 
pyrene and derivatives: 
pyrene 
pyrene butyrate 
succinimidyl 1-pyrene butyrate 
Reactive Red 4 (Cibacron® Brilliant Red 3B-A) 
rhodamine and derivatives: 
6-carboxy-X-rhodamine (ROX) 
6-carboxyrhodamine (R6G) 
lissamine rhodamine B sulfonyl chloride 
rhodamine (Rhod) 
rhodamine B 
rhodamine 123 
rhodamine X isothiocyanate 
sulforhodamine B 
sulforhodamine 101 
sulfonyl chloride derivative ofsulforhodamine 101 (Texas 
Red) 
N,N,N',N'-tetramethyl-6-carboxyrhodamine (TAMRA) 
tetramethyl rhodamine 
tetramethyl rhodamine isothiocyanate (TRITC) 
riboflavin 
rosolic acid 
14 
terbium chelate derivatives 
One of ordinary skill in the art can easily determine, using 
art-known techniques of spectrophotometry, which fluoro-
phores will make suitable donor-acceptor FRET pairs. For 
example, FAM (which has an emission maximum of 525 nm) 
is a suitable donor for TAMRA, ROX, and R6G (all of which 
have an excitation maximum of 514 nm) in a FRET pair. 
10 Probes are preferably modified during synthesis, such that a 
modified T-base is introduced into a designated position by 
the use of Amino-Modifier C6 dT (Glen Research), and a 
primary amino group is incorporated on the modified T-base, 
as described by Ju et al. Proc. Natl. Acad. Sci. USA 92:4347-
15 4351). These modifications may be used for subsequent 
incorporation of fluorescent dyes into designated positions of 
the nucleic acid probes of the present invention. 
The optimal distance between the donor and acceptor moi-
eties will be that distance wherein the emissions of the donor 
20 moiety are maximally absorbed by the acceptor moiety. This 
optimal distance varies with the specific moieties used, and 
may be easily determined by one of ordinary skill in the art 
using well-known techniques. For energy transfer in which it 
is desired that the acceptor moiety be a fluorophore that emits 
25 energy to be detected, the donor and acceptor fluorophores 
are preferably separated when hybridized to target nucleic 
acid by a distance of up to 30 nucleotides, more preferably 
from 1-20 nucleotides, and still more preferably from 2 to 10 
nucleotides and more preferably separated by 3, 4, 5, 6, 7, 8 
30 and 9 nucleotides. For energy transfer wherein it is desired 
that the acceptor moiety quench the emissions of the donor, 
the donor and acceptor moieties are preferably separated by a 
distance ofless than 10, 9, 8, 7, 6, 5, 4, 3, 2, or 1 nucleotide 
(e.g., on the opposite strand, complementary nucleotides of a 
35 duplex structure), although a 5 nucleotide distance (one heli-
cal tum) is also advantageous for use. 
In yet another embodiment, the nucleic acid probes of the 
invention may be further labeled with any other art-known 
detectable marker, including radioactive labels such as 32P, 
40 35 S, 3H, and the like, or with enzymatic markers that produce 
detectable signals when a particular chemical reaction is con-
ducted, such as alkaline phosphatase or horseradish peroxi-
dase. Such enzymatic markers are preferably heat stable, so as 
to survive the denaturing steps of the amplification process. 
45 Nucleic acid probes may also be indirectly labeled by incor-
porating a nucleotide linked covalently to a hapten or to a 
molecule such as biotin, to which a labeled avidin molecule 
may be bound, or digoxygenin, to which a labeled anti-
digoxygenin antibody may be bound. Nucleic acid probes 
50 may be supplementally labeled during chemical synthesis or 
the supplemental label may be attached after synthesis by 
methods known in the art. 
The nucleic acid probes of the invention have use in nucleic 
acid detection, or amplification reactions as primers, or in the 
55 case oftriamplification, blocking oligonucleotides, to detect 
or measure a nucleic acid product of the amplification, 
thereby detecting or measuring a target nucleic acid in a 
sample that is complementary to a 3' primer sequence. 
Accordingly, the nucleic acid probes of the invention can be 
60 used in methods of diagnosis, wherein a sequence is comple-
mentary to a sequence (e.g., genomic) of an infectious disease 
agent, e.g. of human disease including but not limited to 
viruses, bacteria, parasites, and fungi, thereby diagnosing the 
presence of the infectious agent in a sample of nucleic acid 
65 from a patient. The target nucleic acid can be genomic or 
cDNA or mRNA or synthetic, human or animal, or of a 
microorganism, etc. 
US 7,399,591 B2 
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In one embodiment the inventor provides a useful screen-
ing tool for drug discovery where a rapid specific and sensi-
tive assay can detect in vivo changes in the expansion role of 
protein transcripts of interest, either at a steady state or in 
response to the administration of drug candidates. In another 
embodiment that can be used in the diagnosis or prognosis of 
16 
a disease or disorder, the target sequence is a naturally occur-
ring or wild type human genomic or RNA or cDNA sequence, 
mutation of which is implicated in the presence of a human 
disease or disorder, or alternatively, the target sequence can 10 
be the mutated sequence. In such an embodiment, optionally, 
the amplification reaction can be repeated for the same 
sample with different sets of probes that amplify, respectively, 
the naturally occurring sequence or the mutated version. By 
way of example, the mutation can be an insertion, substitu- 15 
tion, and/or deletion of one or more nucleotides, or a trans-
location. 
triethyl-ammonium acetate (TEAA) pH 7 .2 over 40 minutes. 
The oligonucleotides were additionally purified by IE-HPLC 
using a Source™ column (Amersham Pharmacia Biotech, 
Piscataway, N .J.) and eluted with a linear 0% to 50% 1 M Li Cl 
gradient in 0.1 M Tris pH 8.0 over 40 minutes. Unmodified 
(target) oligonucleotides were purified using polyacrylamide 
gel electrophoresis. All oligonucleotides were synthesized at 
Integrated DNA Technologies, Inc. (Coralville, Iowa). 
Probe and Target Design. All oligonucleotide probes were 
designed to be complementary in antisense orientation to the 
human GAPDH gene, as illustrated in FIG. 2. Specifically, a 
dabcyl quencher was attached to the 5'-end and a 6-Fam 
fluorophore was attached to the 3'-end of donor molecular 
beacons; a dabcyl quencher was attached to the 3'-end and 
either a Cyanine 3 (Cy3), 6-carboxyrhodamine (ROX), or 
Texas Red fluorophore was attached to the 5'-end of acceptor 
molecular beacons. The stem sequence was designed to par-
ticipate in both hairpin formation and target hybridization 
(Tsourkas et al., 2002b ). This beacon design was chosen to EXAMPLES 
Example 1 
Dual Nucleic Acid Probes 
Oligonucleotide Synthesis. Oligonucleotide probes and 
targets were synthesized using standard phosphoramidite 
chemistry on an Applied Biosystems model 394 automated 
DNA synthesizer (Foster City, Calif.). Molecular beacons 
were purified using dual reverse phase (RP) plus ion-ex-
change (IE) high performance liquid chromatography 
20 help fix the relative distance between the donor and acceptor 
fluorophores and improve energy transfer efficiency. Both the 
donor and acceptor beacons were designed with a probe 
length of 18 bases and a stem length of 5 bases. The probe 
length is defined as the portion of the molecular beacon that is 
25 
complementary to the target. The synthetic wild-type 
GAPDH target has 4-base gap between the donor dye and the 
acceptor dye. Gap spacing was adjusted to 3, 5, and 6 bases by 
either removing a guanine residue or adding 1 or 2 thymine 
residues, as shown in Table 1. 
Name 
Fam donor-MB (ll 
Tb donor probe 
TABLE 1 
Design of Probes and Target Oliqonucleotides 
Sequence (5' -3') 
Dabcyl-ccacaTGATGGCATGGACTGTGG-Fam 
SEQ ID N0,1 
TGATGGCATGGACTGTGG-DTPA-cs124-(Tb) 
SEQ ID N0,2 
Note 
Probe 18/Stem 5 
Probe 18/Stem O 
Cy3 acceptor-MB Cy3-GAGTCCTTCCACGATACCgactc-Dabcyl Probe 18/Stem 5 
SEQ ID NQ,3 
ROX acceptor-MB ROX-GAGTCCTTCCACGATACCgactc-Dabcyl Probe 18/Stem 5 
SEQ ID NQ,4 
Texas Red Texas Red-GAGTCCTTCCACGATACCgactc-Dabcyl Probe 18/Stem 5 
acceptor-MB SEQ ID NQ,5 
Target 12 ' n-i ACTTTGGTATCGTGGAAGGACTCATACCACAGTCCATGCCATCACTGCC 3 base gap 
Target n (WT) 
Target n+l 
Target n+2 
SEQ ID NQ,6 
ACTTTGGTATCGTGGAAGGACTCATGACCACAGTCCATGCCATCACTGCC 
SEQ ID NQ,7 
ACTTTGGTATCGTGGAAGGACTCATTGACCACAGTCCATGCCATCACTGCC 
SEQ ID NQ,8 
ACTTTGGTATCGTGGAAGGACTCATTTGACCACAGTCCATGCCATCACTGCC 
SEQ ID NQ,9 
4 base gap 
5 base gap 
6 base gap 
(llMB = Molecular Beacon. Lower case = bases added to create stem domains. Upper case 
probe-target hybridizing domains. Upper case bold= bases participating in both stem 
formation and target binding 
( 2 lUnderscore = 18 base sequence complementary to MB target binding domains. n = 4 
bases the wild-type gap size 
(HPLC) on a Waters Model 600E HPLC system (Millipore 
Corp., Milford, Mass.). For RP-HPLC purification, oligo-
nucleotides were loaded on a Hamilton PRP-1 column and 
eluted with a linear 5% to 50% acetonitrile gradient in 0.1 M 
Lanthanide Chelate Synthesis. A linear oligonucleotide 
65 with a probe length of 18 bases was labeled at its 3'-end with 
a diethylenetriaminepentaacetic acid (DTPA) chelate 
covalently joined to a sensitizer, cs124 (Cooper and Sammes, 
US 7,399,591 B2 
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2000). As demonstrated in Table 1, the sequence ofthis linear 
probe was identical to the probe domain of the donor molecu-
lar beacons specific for exon 7 of the human GAPDH gene. 
The lanthanide chelate was prepared by first dissolving 
DTPA (500 mg, 1.4 µmole) in 30 mL ofDMF and 1 mL of 
triethylamine. Cs124 (240 mg, 1.4 µmole), dissolved in 4 mL 
ofDMF, was then added dropwise and mixed for 30 minutes. 
To this mixture, 5 mL (75 µmole) ofethylenediamine (EDA) 
was added and stirred at room temperature for two hours. The 
mixture was then stored in the refrigerator overnight. A 
slightly off-white precipitate had formed and was centrifuged 
down further. The DMF supernatant was removed and the 
pellet was washed with isopropanol several times and then 
with ether resulting in a fine white powder, which was dried 
under a vacuum for 2 hours. The powder was resuspended in 
water and RP-HPLC purified using a Hamilton PRP-1 col-
unm. The sample was eluted with a linear 0% to 30% aceto-
nitrile gradient in 0.1 M TEAA pH 7.2 over 20 minutes at a 
flow rate of 10 mL/min. The first peak was collected, and the 
DTPA-cs124 product was dried and reconstituted to a con- 20 
centration of 15 mM in 0.1 M Borate Buffer, pH 8.5. 
10 
15 
Disuccinimidyl suberate (1.84 mg, 5 µmoles; Pierce 
Chemical) was dissolved in 100 µL ofDMSO and added to 
0.1 µmoles of oligonucleotides with a 3'-amine, dissolved in 
100 uL of DMSO. The mixture was incubated at 40° C. for 2 25 
hours. The oligonucleotides were then acetone precipitated 
and reconstituted in 100 µI of0.1 M sodium borate pH 8.5. 50 
uL ofl 5 mM DTPA-cs124-EDA product in borate buffer was 
added to the oligonucleotide solution and mixed overnight. 
Oligonucleotide-DTPA-cs124-EDA conjugates were puri-
fied using reversed-phase (RP) HPLC. The oligonucleotides 
were loaded on a PRP-1 column and eluted with a linear 5% 
30 
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excitation and emission wavelengths of the organic and lan-
thanide dyes used in this study are summarized in Table 2. 
TABLE2 
Maximal Excitation and Emission Wavelengths 
of Organic and Lanthanide Dyes 
Extinction 
Excitation Emission Coefficient 
Dye Molecule (nm) (nm) (M- 1 cm- 1) 
6-Fam 494 518 83,000 
Terbium Chelate 300-340 546 10,000-35 ,000 
Europium Chelate 300-340 620 10,000-35 ,000 
Cy3 552 570 150,000 
Rox 585 605 82,000 
Taxes Red 583 603 116,000 
Note 
Donor 
Donor 
Donor 
Acceptor 
Acceptor 
Acceptor 
FRET of Organic Dye Pairs. A series of solution-phase 
assays were conducted to determine whether the signal gen-
erated by a pair of molecular beacons hybridized to the same 
target oligonucleotide can be differentiated from the signal 
due to false-positive events. For organic dye pairs, the same 
donor beacon (i.e., a molecular beacon with a fluorescent 
donor dye) was tested with three acceptor (reporter) beacons 
for the magnitudes of background signal and positive (FRET) 
signal. Here, "background" is defined as fluorescence 
detected from one or both beacons in the absence of target or 
from either beacon alone in the presence of target. Thus 
background represents any fluorescence emission detected in 
the absence of a FRET event due to the simultaneous hybrid-
ization of the donor and acceptor beacons to the same target. 
If fluorescence excitation is limited to wavelengths Ae optimal 
for the donor fluorophore and signal detection is limited to 
to 50% acetonitrile gradient in 0.1 M TEAA pH 7.2 over 40 
minutes. The collected peak was lyophilized and reconsti-
tuted in dH2 0 at 5 µM. TbCl3 (Terbium) dissolved in PBS was 
then added to the sample at a 10: 1 molar ratio and incubated 
at room temperature for 30 minutes. The Europium chelates 
were synthesized following the same protocol. 
Hybridization and Detection Assays. Hybridization 
experiments were conducted with 50 pmoles of donor bea-
con, 50 pmoles of acceptor beacon and 50 pmoles of comple-
mentary target in a total volume of 100 µL (0.5 µM). All 
experiments were conducted at 37° C. in HB buffer contain-
ing 10 mM KC!, 5 mM MgCl2 , and 10 mM Tris-HCI, pH 7 .5, 
which was supplemented with 1 % Bovine Albumin Serum to 
block non-specific interactions with the microplate. The 
samples were mixed and allowed to equilibrate at 37° C. for 
35 wavelengths Ad optimal for the acceptor (reporter) fluoro-
phore, fluorescent signal should be low unless both beacons 
hybridize to the same target and FRET occurs. However, 
since fluorescence from organic fluorophores occurs over a 
broad range of wavelengths, it is possible for fluorescence 
40 emission from the donor at Ad and from the acceptor due to 
direct excitation at Ae to contribute to background. "Positive 
signal" is defined as FRET-induced fluorescence detected 
when both beacons are bound to the same target, again 
restricting excitation to wavelengths Ae and limiting detection 
45 to wavelengths Ad. 
20 minutes before performing fluorometry. A Satire micro-
plate fluorometer (Tecan, Zurich, Switzerland) was used to 
excite the donor beacons and detect resulting emission (500 50 
nm to 650 µm) in FRET measurements. The excitation wave-
length was varied from 395 nm to 495 nm to determine the 
wavelength that resulted in the maximal FRET between the 
donor and acceptor molecules. In a two-photon experimental 
set-up, the excitation spectra of Fam- and Cy3-labeled linear 55 
oligonucleotides were obtained. A tunable laser was adjusted 
As illustrated in Table 1, the donor molecular beacon was 
labeled with 6-Fam on the 3'-end, and the acceptor molecular 
beacons were labeled with Cy3, ROX, or Texas Red on the 
5'-end. Sequences of donor and acceptor molecular beacons 
were chosen to be complementary to adjacent sites within 
exon 6 and exon 7 of the human GAPDH gene and were 
positioned with a four base separation between donor and 
acceptor fluorophores when wild-type target was used. Four 
types of assays were performed with each donor/acceptor 
beacon pair: (1) both donor and acceptor beacons in the 
to excite the samples at wavelengths ranging from 700 nm to 
875 nm. The fluorescence emission between 505 nm and 555 
nm was detected from the Fam sample and the emission 
between 590 and 650 nm was detected from the Cy3 sample 
using ultra-sensitive, low noise avalanche photodiodes. 
For LRET measurements, the Terbium and Europium 
donor probes were excited at a wavelength of325 nm, and the 
emission was recorded from 500 nm to 650 nm for assays 
with Terbium donors, and from 550 nm to 750 nm for assays 
involving Europium donors. The emission detection had a lag 
time of 50 µs with an integration time of 1 ms. The maximal 
absence of target, with a typical emission spectrum (i.e., 
fluorescence intensity as a function of wavelength) shown as 
curve a in FIG. 3 (spectrum a); (2) donor beacon only in the 
60 presence of target, with a typical emission spectrum shown as 
curve bin FIG. 3 (spectrum b); (3) acceptor beacon only in the 
presence of target, with a typical emission spectrum shown as 
curve c in FIG. 3 (spectrum c ); and ( 4) both donor and accep-
tor beacons in the presence of target, with a typical emission 
65 spectrum shown as curved in FIG. 3 (spectrum d). Assays (2) 
and (3) simulate the limiting false positive scenario where 
most of the molecular beacons open as a result of nuclease 
US 7,399,591 B2 
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degradation, denaturation, or non-specific protein interac-
tions (which hereafter will collectively be referred to as 
'degraded' beacons). 
To illustrate the advantages of using duel FRET molecular 
beacons and to compare the performance of different acceptor 
molecular beacons, several signal-to-background ratios were 
calculated. As illustrated in FIG. 3, the first is S:BdMB' the 
ratio of the peak fluorescence intensity of emission spectrum 
b defined above for donor molecular beacons ( dMB) to that of 
emission spectrum a at the same wavelength. Although spec- 10 
trum a was generated with both the donor and acceptor bea-
cons in solution, the fluorescence signal is largely due to the 
donor beacons, forthe emission of the acceptor beacons at the 
corresponding wavelength is almost zero, as can be seen from 
curve c in FIG. 3. Thus, S:BdMB represents the signal-to- 15 
background ratio of the conventional single molecular beacon 
assay. The second is S:BaMB' the ratio of the peak fluores-
cence intensity of emission spectrum d of the acceptor 
molecular beacon (aMB) due to FRET to that of emission 
spectrum a at the same wavelength. Clearly, S:BaMB repre- 20 
sents the signal-to-background ratio of the dual FRET 
molecular beacons assay without degraded beacons. The 
third one, S:Bdeg' is defined as the ratio of the peak fluores-
cence intensity of emission spectrum d due to FRET to that of 
emission spectrum b or c at the same wavelength, whichever 25 
is higher. S:Bdeg represents the signal-to-background ratio of 
the dual FRET molecular beacons assay for the limiting case 
that most of the donor and acceptor beacons are being 
degraded. Here we assume that, with up to lxl05 molecular 
beacons per cell, the probability of having both degraded 30 
donor and acceptor beacons at the same spatial location (i.e., 
within a cylinder of0.2 µmin diameter and 1 µmin thickness) 
in a fluorescence imaging assay is small. This is especially 
true considering that, with chemical modifications of the 
beacon backbone, only a small fraction ( <50%) of the 35 
molecular beacons would be degraded in an intracellular 
environment. It is worth mentioning that all the signal-to-
background ratios discussed above change with the donor 
excitation wavelength. 
As shown in FIG. 4a, S:BaMB of the FRET assay with 40 
Cy3-labeled acceptor beacons was almost identical to S:B dMB 
of the donor beacon alone over the entire range of excitation 
wavelengths tested. Neither parameter varied significantly, 
ranging between 20 and 25, as the excitation wavelength A 
was increased. The dual FRET molecular beacons, however, 45 
did generate a signal 2 to 3 times stronger compared with that 
of degraded beacons, i.e., S:Bdeg has a value of 2-3, while 
conventional molecular beacons cannot differentiate between 
signals due to degraded and hybridized probes. Signal 
enhancement upon molecular beacon/target binding is 50 
strongly affected by cation concentration and temperature. In 
this case, the S:Bdeg was relatively low since the assay tem-
perature of 37° C. was near the stem melting temperature. 
When a ROX fluorophore was used as the acceptor dye, 
S:BaMB was found to be -10, about half of S:BdMB' at low 55 
excitation wavelengths A (e.g., 395 nm to 425 nm), as shown 
20 
Value of S:BaMB increased from 10 to nearly 50 as A was 
increased from 395 nm to 495 nm. Moreover, as A was 
increased from 455 nm to 475 nm the value of S:Bdeg 
increased from -2 to over 10 and remained around 10 for 
A>475 nm, as demonstrated in FIG. 4c. Therefore, the signal 
generated by binding of both donor and acceptor beacons to a 
target could be 10 times brighter than false-positive signals. 
An example of the spectra generated using the Fam-Texas 
Red FRET pair is given in FIG. 5. 
Although the performance of dual FRET molecular bea-
cons is better than non-FRET molecular beacons due to 
increased signal-to-background ratio and the ability to differ-
entiate between bound and degraded molecular beacons, the 
peak fluorescence intensity of the acceptor beacons was typi-
cally lower than that of the Fam-labeled donor beacons, as 
shown in FIG. 6. Specifically, at wavelengths where optimal 
FRET signal-to-background ratios were obtained, for Fam-
Texas Red FRET pair the peak signal intensity of the acceptor 
was only about 40% of that emitted by the Fam-donor alone, 
and only about 25% forthe Fam-ROX FRET pair, which may 
limit ultimate sensitivity. 
The efficiency E of fluorescence resonance energy transfer 
between thea donor and acceptor fluorophores varies accord-
ing to 
(1) 
where R is the distance between donor and acceptor dyes, and 
R0 is the Forster energy transfer distance or the distance at 
which E=0.5. For typical fluorophores R0=1-5 nm. Equation 
(1) implies thatthe gap (i.e., thenumberofbases) between the 
donor and acceptor beacons should be kept small. However, 
too small a gap size may result in steric interference between 
fluorophores or might lead to other interaction between donor 
and acceptor (such as ground state quenching), which is unfa-
vorable. The gap size can influence the relative orientation of 
the fluorophores, also affecting energy transfer efficiency. A 
gap size of8 bases was found to be optimal for energy transfer 
in the single-stranded random-coil conformation (Ju et al., 
1995; Hung et al., 1997). Further, base composition can influ-
ence fluorescence efficiency. The combination of a fluores-
cein dye attached to a guanine base can decrease peak fluo-
rescence intensity by as much as 30% (M. Behlke, 
unpublished observation). To optimize design parameters, 
hybridization experiments were conducted using targets that 
separate the donor and acceptor beacons by 3, 4, 5, and 6 
bases. The nucleotides closest to the probe-binding region 
were identical for each target sequences. When the distance 
between the donor and acceptor beacons was increased from 
3 to 6 bases, there was a slight increase in the FRET signal 
intensity, as demonstrated by the curves displayed in FIG. 7. 
This trend was found to be the same for all the acceptor 
fluorophores studied. 
LRET of Lanthanide Dyes. Conventional organic dyes 
used for FRET assays are limited by problems associated 
with the overlapping of donor/acceptor excitation and emis-
sion spectra. To dramatically improve the signal-to-back-
ground ratio, the inventor takes advantage of the sharp emis-
sion peaks and the long lifetime of a lanthanide chelate (Li 
and Selvin, 1997; Cooper and Sanrmes, 2000). Specifically, a 
lanthanide donor is substituted for the Fam donor and modi-
fied the detection system to employ time-resolved spectros-
copy. The lanthanide donor was a linear oligonucleotide 
in FIG. 4b. However, when A was increased, S:BaMB also 
increased. In fact, when A became larger than 460 nm, S: B aMB 
was higher than S:BdMB' reaching values above 30. This 
indicates that the dual FRET molecular beacons with a Fam- 60 
ROX FRET pair can perform better than the conventional 
molecular beacons even in the absence of beacon degradation 
issues. The value of S:Bdeg also increased with increasing A, 
reaching values close to 5 at A.=455 nm, remaining between 4 
and 5 for wavelengths ranging from 455 nm to 495 nm. 65 probe labeled at its 3'-end with the Terbium chelate DTPA-
cs124 (Table 1 ). The same series of acceptor molecular bea-
cons were tested as before, including beacons with Cy3, 
Acceptor beacons labeled with Texas Red were found to 
perform the best among the three acceptor dyes considered. 
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ROX, or Texas Red fluorophores. Note that the use of lan-
thanide donor allows for shorter wavelength excitation, as 
demonstrated in Table 2. 
The results ofLRET experiments with a lanthanide donor 
are shown in FIGS. Sa, b. As shown by curve (1) in FIG. Sa, 
at 325 nm excitation, when the Terbium-chelate labeled 
donor probes bound to Cy3 labeled acceptor beacons, they 
exhibited several sharp emission peaks separated by valleys 
with fluorescence intensity close to zero; while the fluores-
cence emission from acceptor molecular beacons alone 10 
hybridized to targets was extremely low, as shown by curve 
(2). With binding of both donor probes with Terbium-chelate 
and acceptor molecular beacons to target, a sensitized emis-
sion of the acceptor due to LRET was observed, shown as 
curve (3).As clearly demonstrated by the insert in FIG. Sa, at 15 
emission wavelengths where background from the lanthanide 
donor was near zero, extremely high signal-to-background 
ratios were observed. For Cy3-labeled acceptor beacon, the 
optimal detection wavelength is around 573 nm. Similar fea-
tures were exhibited in FIG. Sb in which the time resolved 20 
emission spectra obtained with 325 nm excitation in a dual 
LRET probe assay using Terbium chelate as a donor and ROX 
22 
(2)). When both donor and acceptor probes hybridized to the 
same target, there was a sensitized emission of the acceptor 
due to LRET, as shown by curve (3). Evidently, at certain 
wavelengths (such as 670 nm), the background signal due to 
degraded donor and acceptor probes becomes very low, lead-
ing to a high signal-to-background ratio. It was found that 
with the DTPA-cs124 chelate used in this study, the LRET 
probe pairs with a Terbium donor performs better than the 
LRET probe pair with a Europium donor and a Cy5 acceptor. 
Although conventional molecular beacons can in theory 
detect mRNA transcripts in living cells, conditions within the 
intracellular environment can limit their utility in cellular 
imaging of gene expression. Specifically, molecular beacons 
bound to target mRNAs cannot be distinguished from those 
degraded by nucleases, or destabilized due to interactions 
with proteins. Here we report a dual molecular beacon 
method that combines the advantages of molecular beacons 
with two-probe resonance energy transfer methods. Conven-
as an acceptor were displayed. It is again very clear that at 
certain emission wavelengths the signal-to-background ratio 
approaches infinity. As seen from the insert of FIG. Sb, for 
ROX-labeled acceptor beacon, the optimal detection wave-
length is around 614 nm. Although the fluorescence emission 
due to energy transfer was very low, these results nevertheless 
suggest that there is a significant potential for use of lan-
thanide donors with dual energy transfer molecular beacons. 30 
tional and time-resolved fluorescence spectroscopy studies 
indicate that dual FRET molecular beacon pairs are capable 
of distinguishing between bound and degraded beacons with 
improved signal to background than previous methods. 
Moreover, with a lanthanide chelate as the donor dye, the 
signal-to-background ratio can be extremely high at certain 
25 wavelengths. 
To determine the possible detrimental effect of small gap 
size between donor and acceptor probes on LRET, the spac-
ing between the Terbium-labeled donor probe and the Cy3 or 
ROX-labeled acceptor beacon was varied from 3 to 9 bases. It 
was found that the detected fluorescence intensity is not sen- 35 
sitive to the gap spacings tested, i.e., with a spacing of3, 4, 5, 
6 and 9 bases, the signal levels were similar (data not shown), 
suggesting that the possible detrimental effect was negligible 
when both probes hybridized to the target with a relatively 
small gap spacing. Using Equation (1), it is readily shown 40 
that, with the gap spacing varying from 3 to 9 bases, the 
energy transfer efficiency does not change much, since the 
Forster distance R0 for the Terbium/Cy3 LRET pair is large 
(6.12 nm) (Selvin, 2002). For example, when R in Equation 
(1) increases from 1 nm (-3 bases) to 2 nm (-6 bases) and to 45 
3 nm (-9 bases), the energy transfer efficiency E only 
decreases by 0.12% and 1.37%, respectively. 
Due to the narrow emission peaks exhibited by lanthanide 
dyes, and the use of time-resolved fluorescence detection, it is 
not necessary to include a quencher molecule in the acceptor 50 
molecular beacons, although the stem-loop hairpin structure 
of the beacon may still be beneficial. However, when the 
detection of point mutations is not involved, the use of linear 
LRET pairs of oligonucleotide probes is attractive owing to 
its potential in reducing cost while having comparable per- 55 
formance. To demonstrate the concept, donor oligonucleotide 
probes labeled with a Europium chelate at its 3'-end, and 
acceptor oligonucleotide probes labeled at its 5'-end with a 
Cy5 fluorophore were synthesized, and in-solution hybrid-
ization and time-resolved emission detection assays were 60 
performed. The resulting emission spectra are displayed in 
FIG. 9. Similar to the results obtained using Terbium-chelate 
donors, at 325 nm excitation, the emission spectrum of 
Europium donor bound to target showed several peaks within 
the range of 550 nm to 750 nm, as demonstrated by curve (1 ). 65 
The fluorescence emission of the Cy5-labled acceptor probe 
due to probe/target hybridization is again almost zero (curve 
These features are especially important in the detection and 
quantification of gene expression in living cells where false-
positive signals due to probe degradation and interaction with 
DNA binding proteins must be distinguished from the 'true' 
signal that results from probe/target binding. We envision 
widespread applications of the dual energy transfer molecular 
beacon methods in laboratory and clinical studies of gene 
expression in living cells, tissues and even animals using 
single- or multi-photon microscopy, time-resolved fluores-
cence microscopy, and fluorescence endoscopy. For example, 
it is plausible to use this methodology for the specific and 
sensitive detection of the expression of oncogenes and tumor-
suppresser genes in living cells, potentially making it a very 
simple and effective clinical tool for the early detection and 
diagnosis of malignancy. 
When using the dual LRET molecular beacons for gene 
detection and quantification examples of chelates that can be 
employed include DTPA-cs124, BCPDA (4,7-bis(chlorosul-
fophenyl)-1,1 O-phenanthroline-2,9-dicarboxylic acid) and 
BHHCT ( 4,4-bis(l ,1,1,2,2,3,3-heptafluoro-4,6-hexanedion-
6-yl)-chlorosulfo-o-terphenyl (Evangelista et al., 1988; 
Lopez et al., 1993; Yuan et al., 1998; Sueda et al., 2000; 
Cooper and Sanimes, 2000). 
Another improvement is to use two photon excitation 
instead of one-photon excitation. So far, all the dual FRET 
beacon/target hybridization assays performed were based on 
a one-photon excitation source (Xenon flash lamp). However, 
because of the overlapping excitation-emission spectrums of 
the organic donor and acceptor molecules for FRET, it is often 
difficult to excite the donor without also directly exciting the 
acceptor. For example, as demonstrated in FIG. lOa, the 
maximum excitation of a donor Fam molecule occurs at-500 
nm, but at the same wavelength an acceptor Cy3 molecule is 
also excited to 25% of its maximum. Therefore, if an acceptor 
beacon is degraded by nucleases and the fluorophore is sepa-
rated from the dabcyl quencher it will be excited, giving a 
false-positive signal. Ideally, free acceptor fluorophores 
should be minimally excited by the excitation source and the 
only ones that are excited would be those due to FRET when 
both the donor and acceptor beacon are bound to the same 
target. 
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One strategy to minimize the direct excitation of the accep-
tor fluorophore is to use a two-photon excitation source. Two-
photon excitation cross-sections of fluorophores do not nec-
essarily follow the same trends as one-photon excitation 
spectrums. For example, as shown in FIG. lOb, although the 
maximum excitation of Cy3 occurs at higher wavelengths 
than Fam when one-photon excitation is used, with two-
photon excitation the Cy3 fluorophore is actually excited at 
lower wavelengths. Further, when a donor Fam molecule is 
maximally excited at - 790 nm, the Cy3 acceptor is only 10 
excited about 4% of its maximum. This alone is more than a 
6-fold reduction in the direct excitation of the Cy3 acceptor 
compared with one-photon excitation. Two-photon excitation 
also has the advantage of reduced photo-bleaching, reduced 
background fluorescence from scattering, and the ability to 15 
penetrate deeper into biological tissue than one-photon exci-
tation. Therefore, two-photon excitation is potentially a pow-
erful approach in dual FRET molecular beacon studies. 
gel electrophoresis. All oligonucleotides were synthesized at 
Integrated DNA Technologies, Inc. (Coralville, Iowa). 
Molecular Beacon Design. Two types of molecular bea-
cons were designed and synthesized; both contain target-
specific probe sequence complementary in antisense orienta-
tion to exon 6 of the human GAPDH gene, a Cy3 fluorophore 
at the 5'-end, and a dabcyl quencher at the 3'-end. As illus-
trated in FIG. lla, one type follows the conventional design 
of molecular beacons in that the target-specific probe domain 
was centrally positioned between two complementary arms 
that form the stem; the sequence of these arms were indepen-
dent of the target sequence. Shared-stem molecular beacons, 
on the other hand, were designed to have one arm of the stem 
complementary to the target sequence, as shown schemati-
cally in FIG. llb. In both cases, the probe length LP is defined 
as the portion of the molecular beacon that is complementary 
to the target, and the stem length Ls is the number of bases of 
each complementary arm. All the molecular beacons had 
Example 2 
Shared Stem Nucleic Acid Probes 
Oligonucleotide Synthesis. Oligonucleotide probes and 
targets were synthesized using standard phosphoramidite 
chemistry on an Applied Biosystems model 394 automated 
DNA synthesizer (Foster City, Calif.). Molecular beacons 
were purified using a 2-step reverse phase (RP) plus ion-
exchange (IE) high performance liquid chromatography 
(HPLC) on a Waters Model 600E HPLC system (Millipore 
Corp., Milford, Mass.). For RP-HPLC purification, oligo-
nucleotides were loaded on a Hamilton PRP-1 column and 
eluted with a linear 5% to 50% acetonitrile gradient in 0.1 M 
triethyl-ammonium acetate (TEAA) pH 7 .2 over 40 minutes. 
The oligonucleotides were additionally purified by IE-HPLC 
using a Source™ column (Amersham Pharmacia Biotech, 
Piscataway, N.J.) and eluted with a linear0% to 50% 1 M Li Cl 
gradient in 0.1 M Tris pH 8.0 over 40 minutes. Unmodified 
(target) oligonucleotides were purified using polyacrylamide 
20 LP =19 bases (see Table 3). Conventional molecular beacons 
were synthesized with Ls=4, 5 and 6 bases. The shared-stem 
molecular beacons were synthesized with Ls=4, 5 and 7 
bases. As illustrated by FIG. 12a, a 6-base stem may not be 
synthesized because the shared-stem molecular beacon 
25 sequence is constrained, i.e., part of the arm sequence that 
makes up the 6-base stem is predetermined since the 5'-end of 
the shared-stem molecular beacon must complement the tar-
get sequence and the 3'-stem is created solely to complement 
the 5'-stem sequence. This inadvertently forces an additional 
30 base pairing in the stem. It should be noted that the stem 
sequence of a shared-stem molecular beacon is not adjustable 
since one arm of the stem is designed to complement the 
target. This limitation often precludes the design of certain 
stem/probe length combinations, as demonstrated in FIG.12b 
35 for a molecular beacon with a probe length of 18 bases and a 
stem length of 4 bases. Five target oligonucleotides were also 
synthesized, one wild-type and four with mismatches at 
assorted locations, as shown in Table 3. 
TABLE 3 
The Design of Probes and Target Oliqonucleotides 
Name Sequence (5' -3') Notes 
Shared-stem 19/4 Cy3-GAGTCCTTCCACGATACCActc-Dabcyl Probe 19/Stem 4 
SEQ ID NQ,13 
Shared-stem 19/5 Cy3-GAGTCCTTCCACGATACCAgactc-Dabcyl Probe 19/Stem 5 
SEQ ID N0,14 
Shared-stem 19/7 Cy3-GAGTCCTTCCACGATACCAggactc-Dabcyl Probe 19/Stem 7 
SEQ ID N0,15 
Conventional 19/4 Cy3-cctcGAGTCCTTCCACGATACCAgagg-Dabcyl Probe 19/Stem 4 
SEQ ID N0,16 
Conventional 19/5 Cy3-ctgacGAGTCCTTCCACGATACCAgtcag-Dabcyl Probe 19/Stem 5 
SEQ ID N0,17 
Conventional 19/6 Cy3-ctgagcGAGTCCTTCCACGATACCAgctca-Dabcyl Probe 19/Stem 6 
SEQ ID N0,18 
Target WT 
Target A 
Target B 
ACTTTGGTATCGTGGAAGGACTCATGA 
SEQ ID N0,19 
ACTTTGGTATCGTGGAAGGAaTCATGA 
SEQ ID N0,20 
ACTTTGGTATCGTaGAAGGACTCATGA 
SEQ ID N0,21 
Perfect match 
Single mismatch 
Single mismatch 
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TABLE 3-continued 
The Design of Probes and Target Oliqonucleotides 
Name 
Target C 
Target D 
Sequence ( 5' -3') 
ACTTTGGTATCGTaGAAGGAaTCATGA 
SEQ ID N0,22 
ACTTTGGTATCGTaaAAGGACTCATGA 
SEQ ID N0,23 
Notes 
Double mismatch 
Double mismatch 
(1) Molecular Beacons: Lower case= bases added to create stem domains. 
Upper case =probe-target hybridizing domains. Upper case bold= bases par-
ticipating in both stem hairpin and target binding 
(2) Targets: Underscore = 19 base sequence complementary to beacons. Lower 
case bold = mismatch bases in targets 
Equilibrium Analysis. Molecular beacons in the presence 
of target were assumed to exist in three phases: 1) as duplex 
with target, 2) as stem-loop hairpin, and 3) in random coil 20 
conformation. Dissociation constants describing the transi-
tion between these phases were determined by analyzing the 
thermal denaturation profile of molecular beacons in the pres-
ence and absence of target (Bonnet et al., 1999). Denaturation 
profiles were obtained by recording the fluorescence intensity 25 
of a 50 µL solution containing 200 nM of molecular beacon in 
the presence of 0 to 20 µM of target at temperatures ranging 
from 5° C. to 95° C. Specifically, the temperature of the 
hybridization solution was brought to 95° C. and reduced by 
1 ° C. increments to 5° C. The temperature was then raised 30 
with 1 ° C. increments back to 95° C. to ensure that the 
solution reached equilibrium and no hysteresis had occurred. 
The temperature was held at each temperature increment for 
ten minutes and fluorescence 
was measured for the final 30 seconds. The fluorescence 35 
intensity of each test solution was adjusted to correct for the 
intrinsic variance of fluorescence over temperature. Each 
thermal denaturation assay was performed in hybridization 
buffer containing 10 mM Tris, 50 mM KC!, and 5 mM MgCl2 . 
The fluorescence intensity data describing the thermal 40 
denaturation profile of each molecular beacon and molecular 
beacon-target duplex was used to determine the respective 
dissociation constant as described in Bonnet et al. 1999. Spe-
cifically, dissociation constants K12 characterizing the transi-
tion between phase 1 (bound to target) and phase 2 (closed 45 
beacon) of molecular beacons were obtained for all beacon-
target pairs and for all molecular beacons in the absence of 
target. Further, the dissociation constants K12 were used to 
determine the changes in enthalpy ( llH 12) and entropy ( llS 12) 
associated with each beacon-target duplex. The errors calcu- 50 
lated for the thermodynamic parameters signify a 95% con-
fidence interval. 
Molecular Beacon Specificity. The fraction of molecular 
beacons bound to target, a, was calculated for each molecular 
beacon-target pair as a function of temperature. All calcula- 55 
tions utilized the thermodynamic parameters, enthalpy 
change llH12 and entropy change llS12, obtained from the 
thermal denaturation profiles for each beacon-target duplex 
1 M (Ratilainen et al., 1998). The value of a was calculated for 
each molecular beacon-target pair as a function of tempera-
ture for samples containing B0 =200 nM of molecular beacon 
and T0 =400 nM of target. The melting temperature 8m is 
defined as the temperature at which half of the molecular 
beacons are bound to target, i.e., a=0.5. 
Kinetic Analysis. A SPEX fluorolog-2 spectrofluorometer 
with an SFA-20 rapid kinetics stopped-flow accessory and a 
temperature/trigger module (SFA-12) was used to measure 
molecular beacon-target binding kinetics. Specifically, the 
fluorescence intensity emitted from a rapidly mixed solution 
containing 250 nM molecular beacons and 2.5 µM targets was 
recorded over time for each molecular beacon-target pair. The 
hybridization reaction was assumed to obey the second order 
reaction kinetics 
k1 
B+T ;2D. 
k2 
d[D] 
- =k1[B][T]-k2[D] 
dt 
(3) 
where [BJ, [T] and [DJ are the concentrations of unbound 
molecular beacon, unbound target, and molecular beacon-
target duplex, respectively; k1 is the on-rate and k2 the off-rate 
of molecular beacon-target hybridization. The exact solution 
of Equation 3 gives 
(4) 
where ll=~(B0+T0+K12)2-4B0T0 , [Deq]=(B0 +T0 +K12-i'l)/2, 
A.=[Deq] 2 /B0T0 , and K12=k2/k1 is the dissociation constant 
discussed above. Since the concentration of molecular bea-
con-target duplex is unknown at any given time, it was 
assumed that (F(t)-F 0 )/(F eq-F 0 )=[D(t)]/[Deq]where F(t) is 
the fluorescence intensity at time t, F 0 is the initial fluores-
cence intensity, and Feq is the fluorescence intensity as t---;.oo. 
In order to obtain the on-rate k 1 based on the fluorescence 
measurement, two different curve-fitting schemes were used. 
___ a: ___ = e(-!:.H12/R(!)+(!:.S12/R) (2) 
60 The first utilized a least-square method by fitting a straight 
line to a logarithmic form of Equation 4, 
(1-a:J('l-a:Jilo 
where 8 is the temperature in Kelvin, R is the gas constant, 65 
11=T0/B0 , B0 =B0/ c0 , T 0 and B0 are respectively initial concen-
tration of target and beacons, and c0 is the unit concentration 
1 ( {F(t)-Fo)) 1 ( {F(t)-Fo)) 
-ln 1- = -ln 1-A -k1 t Ll {F,q - F0 ) Ll {F,q - F0 ) 
(5) 
US 7,399,591 B2 
27 
with a slope equal to k 1 . Alternatively, a non-linear least-
square method was used to determine the value of k 1 from 
Equation 4 directly. The results obtained using these two 
approaches were compared. 
28 
part of the stem (one arm) is bound to the target, it is less likely 
to interact with its complementary arm, resulting in a more 
stable probe/target duplex. In contrast, the arms of a conven-
tional molecular beacon do not bind to the target and are thus 
more likely to interact with each other as driven by thermal 
energy, increasing the tendency of forming a closed molecu-
lar beacon by dissociating from the target. Not surprisingly, 
the stem length of a molecular beacon influenced the equilib-
rium state of both the shared-stem and conventional beacons 
in the presence of target. As shown in FIG. 14, as the stem 
length was increased from 4 to 6 bases, conventional molecu-
lar beacons were found to dissociate from target molecules 
more readily. A very similar trend was true for shared-stem 
molecular beacons (data not shown). This indicates that 
Thermal Analysis. To better understand how the perfor-
mance of shared-stem molecular beacons differ from that of 
the conventional molecular beacons, thermodynamic param-
eters of these two types of molecular beacon were obtained 
and compared. In particular, the enthalpy and entropy 
changes li.H12 and li.S 12 describing the phase transition 10 
between bound-to-target and stem-loop conformations were 
determined for conventional and shared-stem molecular bea-
cons using van't Hoff plots. As demonstrated in FIG. 13, these 
plots display the inverse of melting temperature 1/8 mas deter-
mined by R ln(T0 -0.5B0 ) shown as the ordinate. Since at 
melting temperature, 
15 hybridization is less favorable for molecular beacons with 
longer stems. 
1 
Rln(To -0.SBo) = -llH12- + llS12 
em 
(6) 
the slope of the fitted straight line of each curve in FIG. 13 
represents the enthalpy change-li.H12 and they-intercept rep-
resents the entropy change li.S 12 . It was found that in general, 
the shared-stem molecular beacons have a higher melting 
temperature, i.e., they form more stable probe/target duplexes 
than conventional molecular beacons. The changes of 
enthalpy and entropy for all the molecular beacon-target com-
binations tested are summarized in Table 4. 
TABLE4 
The changes in enthalpy and entropy that control the dis-
sociation of conventional and shared-stem molecular beacons 
from targets with mismatches were also determined (see 
20 Table 4). It was found that shared-stem molecular beacons 
formed more stable duplexes with each of the target mol-
ecules tested. However, as displayed in FIG. 15, when point 
mutations were present in the target oligonucleotide, both 
types of molecular beacons dissociated from their targets 
25 more readily. The magnitude of change depended on both the 
number of mismatches and their location. Compared with the 
wild-type target, a point mutation nearthe centerof the probe-
binding domain (Target B) was found to have a larger effect 
on molecular beacon dissociation than a mutation near the 
end of the probe-binding domain (TargetA).As expected, two 
Changes in Enthalpy and Entropy of Conventional and Shared-stem 
Molecular Beacons in the Presence of Target 
Conventional Molecular Beacons Shared-stem Molecular Beacons 
Probe Stem -/lH /lS Stem -/lH /lS 
Target Length Length (kJ/mol) (kJ/mol · K) Length (kJ/mol) (kJ/mol · K) 
WT 19 4 823 ± 168 2281 ± 489 4 862 ± 116 2383 ± 336 
A 19 4 577 ± 62 1595 ± 184 4 708 ± 36 1967 ± 106 
B 19 4 527 ± 27 1471 ± 79 4 586 ± 54 1628 ± 161 
c 19 4 472 ± 23 1336 ± 70 4 478 ± 49 1340 ± 148 
D 19 4 480 ± 38 1352±115 4 521 ± 87 1461 ± 262 
WT 19 649 ± 28 1784 ± 83 690 ± 16 1887 ± 46 
A 19 418 ± 23 1133 ± 70 446 ± 20 1205 ± 59 
B 19 385 ± 24 1055 ± 73 391±24 1057 ± 72 
c 19 324 ± 17 901 ± 54 369 ± 57 1025±175 
D 19 291±25 790 ± 76 319 ± 28 861 ± 85 
WT 19 467 ± 16 1265 ± 48 7 413 ± 10 1096 ±28 
A 19 404 ± 25 1105 ± 76 7 370 ± 13 998 ± 38 
B 19 380 ± 26 1055 ± 79 7 351 ± 39 956±117 
c 19 367 ± 19 1058 ± 61 7 260 ± 30 707 ± 93 
D 19 373 ± 29 1065 ± 91 7 245 ± 25 653 ± 79 
To minimize the number ofindependent variables involved 
in controlling probe/target hybridization, all the molecular 
beacons were designed to have identical probe sequences. 
Further, for molecular beacons with a stem length of 5 bases 
and a probe length of 19 bases, the stem sequence of the 
conventional molecular beacons was chosen such that ener-
getically the stem was similar to that of the shared-stem 
molecular beacons. The free energy changes were calculated 
using nearest neighbor approximations (Zucker 2000). 
55 point mutations (Targets C and D) on a target had a more 
profound effect on the dissociation of molecular beacons 
from targets than that with one point mutation. 
The difference in thermodynamic behavior between con-
ventional and shared-stem molecular beacons can be under-
stood in terms of the ability of the flanking arms to interact 
with each other. With shared-stem molecular beacons, once 
Melting Temperature. To further elucidate the effect of 
molecular beacon structure on the stability of the probe-target 
60 duplex, the melting temperatures em for conventional and 
shared-stem molecular beacons with a probe length of 19 
bases and stem lengths ranging from 4 to 7 bases were com-
pared, as shown in FIG. 6. It was found that conventional 
molecular beacons had lower melting temperatures than 
65 shared-stem molecular beacons for each of the stem lengths 
considered; however, both types of molecular beacons exhib-
ited similar trends. Specifically, the melting temperature pro-
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gressively decreased as the stem length increased. In fact, it 
appears that the melting temperature would be quite low for 
conventional molecular beacons with a probe length of 19 
bases and a stem length of7 bases or greater. This is because 
that with long free arms of the stem a bound molecular beacon 
is very easy to dissociate from the target and form a stable 
hairpin structure even at low temperatures. 
Molecular Beacon Specificity. Melting curves that display 
the fraction of molecular beacons in duplex form, a, as a 
function of temperature were obtained for each molecular 10 
beacon and probe-target pair. As demonstrated in FIG. l 7a, 
the difference in melting temperature em (i.e., temperature at 
a=0.5) between beacon/wild-type-target and beacon/mutant-
target duplexes was found to be slightly larger for conven-
tional molecular beacons compared with corresponding 15 
shared-stem molecular beacons. Further, the difference in the 
fraction of molecular beacons bound to wild-type target and 
mutant target, a wrararget B' as a function of temperature was 
found to be similar for conventional and shared-stem molecu-
30 
probes. However, to optimize the performance of molecular 
beacons for different applications, it is necessary to under-
stand their structure-function relationships. Here is described 
a new design of molecular beacons, i.e., the shared-stem 
molecular beacons, of which the stem-arm nearest the 
reporter dye participates in both hairpin formation and target 
hybridization. In contrast to conventional molecular beacons 
whose stems are independent of the target sequence and thus 
can freely rotate around the probe-target duplex, this new 
design helps immobilize the fluorophores of molecular bea-
cons when they hybridize to the target, which is desirable 
when two molecular beacons are used in a fluorescence reso-
nance energy transfer (FRET) assay (Tsourkas and Bao 
2001). Specifically, with shared-stem molecular beacons, 
there is a better control of the distance between the donor dye 
on one beacon and the acceptor dye on the other beacon, since 
the rotational motion of the fluorophore-attached stem-arm is 
constrained, as illustrated in FIG. llb. To facilitate the design 
and application of, and to reveal the differences between, 
shared-stem and conventional molecular beacons, we per-
formed a systematic study of the thermodynamic and kinetic 
parameters that control the hybridization of these molecular 
beacons with complementary and mismatched targets. 
In general, it was found that compared with shared-stem 
lar beacons, although the maximum value of awrararget Bis 20 
slightly higher for the former, as shown in FIG. 15b. The 
conventional molecular beacons was also found to maintain a 
value of awr-ararget B>O over a slightly broader range of 
temperatures than shared-stem molecular beacons, but again 
the different is very small. This implies that the conventional 
molecular beacons may exhibit only a slightly higher speci-
ficity than shared-stem molecular beacons. 
25 molecular beacons, conventional molecular beacons form 
less stable duplexes with single-stranded nucleic acid targets 
but have a slightly improved ability to discriminate between 
wild-type and mutant targets. The difference in the duplex 
stability can be explained by the thermal-driven interactions 
The effect of stem length on molecular beacon specificity 
was also found to be similar for conventional and shared-stem 
molecular beacons. Specifically, the curves in FIG. 18 dem-
onstrate that, as the stem length is increased the heightened 
competition between a unimolecular reaction and bimolecu-
lar hybridization broadens the transition between bound and 
unbound states. This results in an improved ability to dis-
criminate between targets over a wider range of temperature 
but lowers the maximum difference in the fraction of beacons 
bound to wild-type and mutant targets. 
Kinetic Analysis. The on-rate of shared-stem and conven-
tional molecular beacons hybridized to wild-type target as a 
function of stem length is displayed in FIG.19a. It is seen that 
for shared-stem molecular beacons, an increase in stem 
length from 4 to 5 bases induced a 5-fold reduction in its 
on-rate, which was further reduced by 3-fold when the stem 
length was increased from 5 to 7 bases. In contrast, the on-rate 
30 between the two stem-forming arms after the molecular bea-
con hybridized to a target molecule. Unlike linear oligonucle-
otide probes, a molecular beacon can have two stable confor-
mations: bound to target, and as a stem-loop hairpin. These 
two stable states compete with each other, giving rise to an 
35 improved specificity. The additional freedom inherent in both 
arms of conventional molecular beacon increases the likeli-
hood that, driven by thermal fluctuations, these arms will 
encounter with each other, allowing the molecular beacon to 
dissociate from the target with a higher probability. This 
40 reduced stability also corresponds to a smaller value in the 
free energy difference between bound and unbound states of 
the probe-target duplex. The change in free energy due to any 
mismatch between the probe and target, therefore, will have a 
more profound effect on the preference of the stem-loop 
45 hairpin conformation of the conventional molecular beacons, 
leading to an improved ability to differentiate between wild-
type and mutated targets. However, this improvement was 
found to be marginal. 
of conventional molecular beacons only decreased slightly 
when the stem length was increased from 4 to 6 bases. It is 
interesting to note that, with stem lengths of 5 bases or larger, 
the shared-stem and conventional molecular beacons have 
on-rates differing only by less than a factor of2. However, the 
shared-stem molecular beacons with a 4-base stem hybrid-
ized to wild-type targets four times faster than the corre-
sponding conventional molecular beacons. This large differ-
ence in the rate of hybridization most likely resulted from the 
variations in the stability of the hairpin structure. To further 
illustrate, the dissociation constants K23 of the conventional 
and shared-stem molecular beacons in the absence of target 
are shown in FIG. l9b. Interestingly, there seems to be a clear 
correlation between the on-rate of beacon hybridization and 
the stability of the stem-loop structure. This is understandable 
since K23 represents the transition from hairpin (phase 2) to 60 
random coiled (phase 3) conformations of molecular bea-
cons, and a higher K23 implies that the molecular beacons are 
easier to open. 
With any given probe length and sequence, the hybridiza-
50 tion kinetics of molecular beacons appears to be primarily 
dependent on the length and sequence of the stem, regardless 
of whether they are designed in the conventional or shared-
stem configuration. Both types of molecular beacons exhib-
ited comparable hybridization rates when the dissociation 
55 constants describing the thermal fluctuation induced opening 
of the stem-loop structure, K23 , were similar. When the dif-
ference in K23 for the shared-stem and conventional molecu-
lar beacons was increased, so was the difference in the hybrid-
ization on-rate. 
In addition to the above-mentioned differences in the 
behavior of shared-stem and conventional molecular bea-
cons, the choice of the stem length is independent of the probe 
length for conventional molecular beacons, whereas there are 
certain constraints on the stem-length and probe-length com-
binations in designing the share-stem molecular beacons. 
This, together with the dependence of the thermodynamic and 
Molecular beacons have become a very useful tool for 
many homogeneous single-stranded nucleic acid detection 65 
assays due to their ability to differentiate between bound and 
unbound states and their improved specificity over linear kinetic properties on the probe and stem lengths demon-
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strated in this study, should be considered in the design of 
molecular beacons for specific applications. 
Example 3 
K-ras and Survivin Detection 
32 
patients and other normal tissues makes it an ideal molecular 
marker for the detection of pancreatic cancer cells. Although 
molecular beacons can be designed to target alterations of 
many oncogenes and tumor-suppressor genes, in the pro-
posed study we opt to focus on the detection ofK-ras muta-
tions and the expression of survivin in pancreatic cells. 
It is well established that cancer cells develop due to 
genetic alterations in oncogenes and tumor suppressor genes 
and abnormalities in gene expression that provide growth 10 
advantage and metastatic potential to the cells. A critical step 
It has been shown that K-ras mutations can be detected in 
blood, pancreatic juice and pancreatic tissue samples of pan-
creatic cancer patients using DNA purification and mutant-
enriched PCR followed by single strand conformation poly-
morphism (SSCP), restnct10n fragment-length 
in diagnosing and treating cancer in its early stages is to detect 
cancer cells based on the genetic alterations. An important 
example is pancreatic cancer, the fifth most fatal cancer in the 
US. Only 12% of patients diagnosed with pancreatic cancer 15 
can survive for one year; the 5-year overall survival rate is 
approximately 3-5%. The main reason for the poor prognosis 
polymorphisms (RELP), or allele-specific oligodeoxynucle-
otide hybridization (ASOH). Although identification ofK-ras 
mutations by PCR is a fairly sensitive molecular approach, 
the procedures for PCR and subsequent assays are very time-
consuming, making them difficult to become clinical proce-
dures. Furthermore, detection of K-ras mutations in DNA 
from peripheral blood or pancreatic juice alone is not suffi-
cient for diagnosis of pancreatic cancer since it lacks the 
specificity for the determination of the cellular origin of the 
K-ras mutation. A better way to detect pancreatic cancer is to 
of pancreatic cancer is that very few of these cancers can be 
found early. Current clinical diagnostic procedures such as 
CT-scan and endoscopic retrograde cholangiopancreatogra- 20 
phy (ERCP) have a low sensitivity in detecting pancreatic 
tumors less than 2 cm in size. In spite of the extensive bio-
medical research efforts during the last few decades, over 
90% of the patients with pancreatic cancer have already 
undergone local and/or distant metastases by the time of 25 
diagnosis, often making it too late to cure. Therefore, it is 
extremely important to detect pancreatic cancer in its early 
stages based on molecular markers rather than the size of the 
tumor. 
use nucleic acid probes of the present invention to detect 
K-ras mutations in cancer cells directly. Utilization of prior 
nucleic acid probes to detect K-ras mutations in PCR prod-
ucts of DNA samples isolated from lung cancers has been 
reported and the specificity has been established. However, to 
date the use of nucleic acid probes for the detection of mutant 
K-ras mRNA in intact tumor cells has not been reported. One 
advantage of using the molecular beacons approach is that a 
cocktail of multiple such probes can be delivered into cells for 
different molecular markers of cancer. 
A novel way of achieving early detection of cancer is to 30 
identify cancer cells through detection of mRNA transcripts 
that exist in cancer cells but not in normal cells. Here is 
demonstrated the dual-FRET molecular beacons of the 
present invention for the early detection of cancer cells. 
An important issue in detecting K-ras mutations in cells is 
that as a signaling protein the expression level of K-ras 
mRNA may not be very high ( < 1,000 copies per cell), even in 
K-ras is one of the most frequently mutated genes inhuman 
cancers. A member of the G-protein family, K-ras is involved 
in transducing growth-promoting signals from the cell sur-
face. Point mutations of K-ras are found in 80-100% of pan-
creatic, 40-60% of colon, and 25-50% oflung adenocarcino-
mas, suggesting that mutant K-ras is a sensitive marker for 
pancreatic cancer detection. Further, K-ras mutations occur 
almost exclusively in three hot spots (codons 12, 13 and 61). 
Most of them are concentrated at codon 12, which facilitates 
the design of molecular beacons. Since K-ras mutations occur 
very early in the development of pancreatic cancer, assays 
targeting K-ras mutations can lead to early detection of pan-
creatic carcinomas. Other oncogenes and tumor-suppressor 
genes involved in pancreatic cancer include p53, p16, 
MADH4, DPC4, BRCA2, MKK4, STKll, TGFBRl and 
TGFBR2. 
There is increasing evidence recently suggesting that sur-
vivin, one of the inhibitor of apoptosis proteins (IAPs ), is a 
good tumor marker for several types of cancers. Survivin is 
normally expressed during fetal development but not in most 
normal adult tissues. However, high levels of survivin are 
detected in many human cancer types and transformed human 
cells. In particular, a recent study has demonstrated the pres-
ence of survivin in 77% (20 out of26 cases) of pancreatic duct 
cell adenocarcinomas by immunohistochemistry, immunob-
lotting and RT-PCR assays. The results from this study also 
suggested that the expression of survivin is present in early 
stages of neoplastic transition in pancreatic cancer cells. 
However, expression of survivin was not detected in pancre-
atic tissues obtained from 5 normal persons and 12 patients 
with chronic pancreatitis, nor was it found in inflanimatory 
cells around tumor cells. The absence of survivin expression 
in normal pancreas, pancreatic tissue of chronic pancreatitis 
35 cancer cells. Further, the secondary structures of K-ras and 
survivin mRNAs may influence the binding between nucleic 
acid probes of the present invention and the targets. Thus, it is 
preferred to optimize the design of molecular beacons and the 
beacon delivery conditions so that high detection specificity 
40 and sensitivity can be achieved. By routinely combining the 
nucleic acid probes of the present invention approach with 
high-sensitivity fluorescence microscopy, it will likely be 
possible to detect as few as 10 copies of mRNA per cell. 
To further examine probe-target hybridization and energy 
45 transfer between nucleic acid probes of the present invention, 
dual-FRET molecular beacons were designed and synthe-
sized. Specifically, the molecular beacons were designed to 
target human GAPDH mRNA. The donor proes were synthe-
sized with a 6-FAM donor fluorophore (D) at the 3' end and a 
50 Dabcyl quencher (Q) atthe 5' end. Similarly, acceptor probes 
were synthesized with a Cy3 acceptor fluorophore (A) at the 
5' end and a Dabcyl quencher (Q) at the 3' end (see Table 5 
below). The donor and acceptor beacons are chosen such that 
they are complementary to part of the target sequence. The 
55 loop portion, therefore, is 13 bases in length. The synthetic 
targets mimicking the GAPDH IVT RNA exon 6/exon 7 
junction are designed so that the gap between the two beacons 
hybridizing on the same target is respectively 3, 4, 5 or 6 
bases, with 4-base gap being that of the wild-type. All the 
60 nucleic acid probes of the present invention were synthesized 
at Integrated DNA Technologies (IDT, Inc). 
As illustrated above, thermodynamics and binding kinetics 
of molecular interactions underlies the design of the nucleic 
acid probes of the present invention. The free energy differ-
65 ence between keeping the stem-loop structure and forming 
the probe-target duplex is the main driving force for hybrid-
ization. The nucleic acid probes of the present invention can 
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mRNA targets, the corresponding mutated K-ras mRNA tar-
gets and survivin targets at different probe/target concentra-
tions. Thermal denaturation profiles are generated and the 
corresponding transition temperatures obtained. Since the 
detection specificity depends on the initial concentrations of 
probes and targets, the results of this study not only demon-
strate the detection specificity but also provide guidelines for 
optimizing beacon delivery conditions. Furthermore, 
stopped-flow studies of the hybridization kinetic rates are 
have three different phases in solution: hairpin, random coil, 
and probe-target duplex. The relative portions of these phases 
depend on the structure of the probe, probe and target con-
centrations, solution chemistry, sequences of the probe and 
target, and temperature. For example, if the stem length is too 
large, it will be difficult forthe stem-loop probe to open upon 
hybridization. On the other hand, if the stem length is too 
small, a large fraction of probes may open due to Brownian 
forces. Similarly, relative to the stem length, a longer probe 
may lead to a lower dissociation constant, however, it may 
also reduce the specificity, since the relative free energy 
change due to one-base mismatch would be smaller. 
To further establish the structure-function relationships of 
probes, one can for example routinely design and synthesize 
10 performed with each nucleic acid probe of the present inven-
tion design and each target type. This helps select the optimal 
structure of the nucleic acid probes of the present invention 
with the best possible combination of specificity and rate of 
a series of dual-FRET probes for targeting different K-ras 15 
codon 12 mutations, such as shown in Table 5. For each pair 
hybridization. 
To address potential issues with secondary structures of the 
mRNAs, synthetic targets with lengths three to four times the 
probe length are used in in-solution studies. To further utilize 
the nucleic acid probes of the present invention, total mRNAs 
of survivin and the mutant K-ras are isolated from pancreatic 
of donor and acceptor beacons, the donor beacon will contain 
one of the most common K-ras point mutations in pancreatic 
cancer such as GGT-GAT transitions (Gly to Asp) or GGT-
GTT (Gly to Val), GGT-CGT (Gly toArg), GGT-TGT (Gly to 
Cys) transversions. The same acceptor beacon can used with 
20 cancer cells known to carry them, amplified, and in-solution 
hybridization assays are performed to determine the extent of 
binding between the nucleic acid probes of the present inven-
tion and these mRNAs. 
all donor beacons having different mutated sequences. As an 
example, a specific beacon design for nucleic acid probes of 
the present invention has a probe length of21 nucleotides, a 
stem length of 4 nucleotides, and a gap size of 4 nucleotides 25 
between the donor and acceptor beacons bound on the same 
target. One can routinely examine the effect of beacon struc-
ture on hybridization rate and specificity by varying: 1) probe 
length ofl 7, 19 and 21bases;2) stem length of 4 and 5 bases; 
3) gap sizes of 4 and 5 bases between donor and acceptor 30 
beacons along the target mRNA. For different parameter 
combinations, kinetic and thermodynamic modeling 
described above will be performed to build the analysis of the 
experimental data. 
TABLE 5 
As mentioned earlier, in a cellular environment, nucleic 
acid probes can be degraded by cytoplasmic nucleases. To 
address this issue, the present invention provides probes syn-
thesized with structural modifications such as 2'-0-methyl 
ODNs. Methylated-probe/target duplexes are more stable 
than DNA-probe/target duplexes, and methylated nucleic 
acid probes of the present invention hybridize to RNA targets 
faster than DNA probes. After delivery into primary human 
dermal fibroblast (HDF) cells, the fluorescence signal of 
unmodified molecular beacons with a random DNA sequence 
and methylated nucleic acid probes of the present invention 
Design of Molecular Beacons for K-ras Codon 12 Mutation 
Wild-type K-ras (Bases 1-78) 
1 ATGACTGAAT ATAAACTTGT GGTAGTTGGA GCTGGTGGCG 
41 TAGGcaagAG TGCCTTGACG ATACAGCTAA TTCAGAAT 
SEQ ID N0,27 
Dual-FRET Molecular Beacons 
Donor Beacon, 5'-Dabcyl-AGTGCGCTGTATCGTCAAGGCACT-6-Fam-3' 
SEQ ID N0,28 
Acceptor Beacon, 5'-Cy3-CCTACGCCATCAGCTCCGTAGG-Dabcyl-3' Mut, GGT-GAT 
SEQ ID N0,29 
Acceptor Beacon, 5'-Cy3-CCTACGCCAACAGCTCCGTAGG-Dabcyl-3' Mut, GGT-GTT 
SEQ ID N0,30 
Acceptor Beacon, 5'-Cy3-CCTACGCCACGAGCTCCGTAGG-Dabcyl-3' Mut, GGT-CGT 
SEQ ID N0,31 
Acceptor Beacon, 5'-Cy3-CCTACGCCACAAGCTCCGTAGG-Dabcyl-3' Mut, GGT-TGT 
SEQ ID N0,32 
To further increase the detection sensitivity, for example, 
one can synthesize nucleic acid probes of the present inven-
tion to target a second cancer marker, such as survivin, which 60 
is expressed in pancreatic carcinomas but not in normal tis-
sues. 
with the same sequence are monitored over time to determine 
how long these probes can survive in a cellular environment. 
To determine the specificity of the molecular beacons 
approach for detecting K-ras mutations in pancreatic cancer 
cells, nucleic acid probes of the present invention are synthe-
sized to target four different K-ras codon 12 mutations (GGT-To demonstrate the specificity of molecular beacons tar-
geting K-ras point mutations, in-solution hybridization stud-
ies are carried out by mixing the donor nucleic acid probes of 
the present invention with respectively wild-type K-ras 
65 GAT, GGT-GTT, GGT-CGT and GGT-TGT). Delivery, 
hybridization and imaging assays are carried out using pan-
creatic cancer cell lines such as Pane-I (GGT to GAT), 
US 7,399,591 B2 
35 
Capan-I (GGT to GTT), PSN-I (GGT to CGT), and Mia-
paca-2 (GGT to TGT) with the corresponding mutant K-ras 
mRNAs. Also used is the pancreatic cell line BXPC-3 as a 
control which has the 'wild-type' K-ras mRNA. 
Preliminary studies have shown that the K-ras codon I2 
mutation GGT-GAT in Pane- I cell lines has been confirmed. 
Further confirmation of the other three mutations (GGT-GTT, 
GGT-CGT and GGT-TGT) in the corresponding pancreatic 
cancer cell lines using PCR amplification of K-ras exon I 
sequence followed by DNA sequencing is routinely per- 10 
formed. The K-ras mRNA concentration in each cell line is 
also be quantified using real time RT-PCR. During a pilot 
study, the delivery, hybridization, and buffer conditions for 
the nucleic acid probes of the present invention have been 
optimized to target mutant K-ras mRNA in Pane- I cells (with 15 
GGT to GAT mutation). As mentioned earlier, the invention 
provides a preferred condition for this type of probe of I 50 
nM of the probes in Opti-MEM I medium (GIBCO) and 
incubated at 37° C. for 30 to 60 minutes. It is anticipated that 
the optimal delivery and hybridization conditions for nucleic 20 
acid probes of the present invention targeting different mutant 
K-ras mRNAs may vary from those identified. Nucleic acid 
probes of the present invention designed for each specific 
K-ras mutation are incubated with at least four cell lines with 
the optimal delivery condition; these cell lines include the cell 25 
line containing the specific K-ras mutation, the 'wild-type' 
K-ras cell line BXPC-3, and two other cell lines with different 
K-ras mutations. The FRET-induced fluorescence signal in 
cells can be imaged using a confocal microscope. The speci-
ficity of the present probe detection methodology is con- 30 
firmed when strong fluorescence signal are observed only in 
the cell line expressing the corresponding K-ras mutation but 
not in BXPC-3 nor other cell lines. 
Similar assays are routinely performed to examine the 
specificity of survivin-targeting nucleic acid probes of the 35 
present invention using pancreatic cancer cell lines express-
ing different levels of survivin gene as well as the normal 
human fibroblast cells as a control. For example, using RT-
PCR and Northern blotting, the level of survivin expression in 
40 
pancreatic cell line Miapaca-2 ihas been found to be high, in 
BXPC-3 it is much lower, while in HDF the expression level 
is almost zero. The probe sequence of the survivin probes is 
shown in Table 6 and the steps of the assay are similar to that 
described above. The tumor cell lines expressing different 45 
levels of survivin mRNA and the normal cell line HDF are 
incubated with the survivin nucleic acid probes of the present 
invention, and the resulting fluorescence are imaged using a 
confocal microscope. 
TABLE 6 
Design of Molecular Beacons for Survivin mRNA 
Survivin (Bases 1-121) 
36 
A critical issue concerning the specificity of detecting pan-
creatic cancer cells is that both K-ras codon I2 mutations and 
survivin are being expressed in colorectal and lung cancers as 
well. To assure high specificity for detecting cancer cells 
originated from the pancreatic ducts, in addition to using 
nucleic acid probes of the present invention targeting survivin 
and K-ras mutations, a third probe pair for the chymotrypsi-
nogen gene can be synthesized, which is pancreas-specific. 
An example of the design of donor and acceptor probes are 
respectively: donor probe: 5'-AMCA-ACCTGGATGT-
TGTCCTCGTCAGGT-dabcyl-3' SEQ ID N0:36 and accep-
tor probe: 5'-dabcyl-AAGATTGAAGACCTTGGCGAT 
CTT-Diaky laminocoumarin-3' (underlined bases are comple-
mentary bases to form a stem) SEQ ID N0:37. This nucleic 
acid probe pair of the present invention will be delivered into 
pancreatic, lung and colon cancer cell lines as well as the 
normal human fibroblast cell line HDF and the resulting 
fluorescence images recorded. This will assure that only cells 
originated from pancreatic duct are detected. All the detection 
assays with cells are performed at 37° C. The assays deter-
mining detection specificity with lanthanide-dye based 
nucleic acid probes of the present invention are carried out 
using a Satire monochromator reader (Tecan). 
To determine the sensitivity of the probe-based methodol-
ogy in detecting pancreatic cancer cells, pancreatic cancer 
and normal cells are mixed with I: I,000 (i.e., one cancer cell 
in I ,000 normal cells), 1:10,000, 1:100,000 and 1:1,000,000 
ratios and incubate the mixture with the dual-FRET molecu-
lar beacons designed for the specific cancer cell line under 
optimized conditions (probe concentration and duration). 
After placing cells on glass coverslips, FRET-induced fluo-
rescence images of the hybridized nucleic acid probes of the 
present invention in cancer cells are obtained using a confocal 
microscope. Further, a FACS Vantage SE cell sorter (Becton-
Dickinson) is used to sort out the cancer cells in the mixture 
in suspension. The cell sorter, which has a sorting sensitivity 
of I: I 00,000, has three excitation wavelengths: 488 nm, 547 
nm, and UV. The fluorescence emission due to dual-FRET 
probes in cells can be detected by using the proper filter. The 
dual-FRET probe pairs for detecting survivin, K-ras muta-
tions and chymotrypsinogen are so designed such that the 
donor dye molecules are respectively excited with laser at 353 
nm, 488 nm and 54 7 nm. A fluorescence intensity threshold in 
the detection is chosen such that the effect of background due 
to auto-fluorescence of cells and digested nucleic acid probes 
of the present invention is minimized. In this study, the pan-
creatic cell lines Pane-I, Capan-I, PSN-I and Miapaca-2 are 
used as cancer cells, and a human dermal fibroblast cell line 
(HDF) serves as normal cells. 
1 A TGGGTGCCCC GACGTTGCCC CCTGCCTGGC AGCCCTTTCT 
42 CAAGGaccaf CGCATCTCTA CATTCAAGAA CTGGCCCTTC 
82 TTGGAGGGCT GCGCCTGCAC CCCGGAGCGG ATGGCCGAGG 
SEQ ID N0,33 
Dual-FRET Molecular Beacons 
Donor Beacon, 5'-Alexa546-CCTTGAGAAAGGGCTGCCCAAGG-Dabcyl-3' 
SEQ ID N0,34 
Acceptor Beacon, 5'-Dabcyl-CCGCATTGAATGTAGAGATGCGG-Texas Red-3' 
SEQ ID N0,35 
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In obtaining images of hybridized molecular beacons in 
cancer cells, having ultra-sensitive fluorescence measure-
ments is important, since typically only a very small number 
of cancer cells are present in a sample. The FACS Vantage 
Flow Cytometer (cell sorter) will be used due to its very high 
detection sensitivity, capability of 5 color analysis and sort-
ing, wide flexibility of excitation wavelengths, and cross 
beam laser compensation for separation of overlapping exci-
tation. An imaging analysis will also be carried out to enhance 
the results of FRET fluorescence measurements. In this 10 
38 
Evangelista, R. A., A. Pollak, B. Allore, E. F. Templeton, R. C. 
Morton, and E. P. Diamandis. 1988. A new europium che-
late for protein labelling and time-resolved fluorometric 
applications. Clin. Biochem. 21: 173-178. 
Fang, X., J. J. Li, and W. Tan. 2000. Using molecular beacons 
to probe molecular interactions between lactate dehydro-
genase and single-stranded DNA. Anal. Chem. 72:3280-
3285. 
Femino, A. M, F. S., Fay, K. Fogarty, and R. H. Singer. 1998. 
Visualization of single RNA transcripts in situ. Science 
280:585-90. 
Goddard, N. L., Bonnet, G., Krichevsky, 0., Libchaber, A. 
2000. Sequence dependent rigidity of single stranded 
DNA. Phys. Rev. Lett., 85, 2400-2403. 
example, in carrying out imaging assays of detection sensi-
tivity, only nucleic acid probes of the present invention with 
organic dye pairs for FRET will be used, since currently the 
Zeiss confocal microscope and the FACS cell sorter do not 
have an imaging capability with time resolved FRET. 
This example is based on the rational that detection of 
tumor markers including survivin and mutant K-ras mRNAs 
in pancreatic duct cells using dual-FRET nucleic acid probes 
15 Hung, S. C., R. A. Mathies, and A. N. Glazer. 1997. Optimi-
zation of spectroscopic and electrophoretic properties of 
energy transfer primers. Analytical Biochemistry 252:78-
88. 
of the present invention can lead to early diagnosis of pancre-
atic cancer especially in high-risk patients. It demonstrates 20 
that the novel dual-FRET molecular beacons methodology of 
the present invention has the potential to become a simple 
clinical procedure for early detection of pancreatic cancer 
with high sensitivity, specificity, signal-to-noise ratio, and 
efficiency. This is further demonstrated with subsequent 25 
translational research using clinical samples. The same meth-
odology can be rountinely extended to the early detection and 
diagnosis of other cancers, and the study of gene expression 
in live cells relevant to solving other biomedical problems. 
30 
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<160> NUMBER OF SEQ ID NOS, 37 
<210> SEQ ID NO 1 
<211> LENGTH, 23 
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SEQUENCE LISTING 
<213> ORGANISM, Artificial Sequence 
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It will be apparent to those skilled in the art that various 
modifications and variations can be made in the present 
invention without departing from the scope or spirit of the 
invention. Other embodiments of the invention will be appar-
ent to those skilled in the art from consideration of the speci-
fication and practice of the invention disclosed herein. It is 
intended that the specification and Examples be considered as 
exemplary only. Those skilled in the art will recognize, or will 
be able to ascertain using no more than routine experimenta-
tion, many equivalents to the specific embodiments of the 
invention described herein. Such equivalents are intended to 
be encompassed by the following claims. 
<223> OTHER INFORMATION, Description of Artificial Sequence, Probe 
<400> SEQUENCE, 1 
ccacatgatg gcatggactg tgg 
<210> SEQ ID NO 2 
<211> LENGTH, 18 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, Description of Artificial Sequence, Probe 
<400> SEQUENCE, 2 
tgatggcatg gactgtgg 
<210> SEQ ID NO 3 
<211> LENGTH, 23 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
23 
18 
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-continued 
<220> FEATURE, 
<223> OTHER INFORMATION, Description of Artificial Sequence, Probe 
<400> SEQUENCE, 3 
gagtccttcc acgataccga etc 
<210> SEQ ID NO 4 
<211> LENGTH, 23 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, Description of Artificial Sequence, Probe 
<400> SEQUENCE, 4 
gagtccttcc acgataccga etc 
<210> SEQ ID NO 5 
<211> LENGTH, 23 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, Description of Artificial Sequence, Probe 
<400> SEQUENCE, 5 
gagtccttcc acgataccga etc 
<210> SEQ ID NO 6 
<211> LENGTH, 49 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, Description of Artificial Sequence, Synthetic 
target oligonucleotide 
<400> SEQUENCE, 
actttggtat cgtggaagga ctcataccac agtccatgcc atcactgcc 
<210> SEQ ID NO 7 
<211> LENGTH, 50 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, Description of Artificial Sequence, Synthetic 
target oligonucleotide 
<400> SEQUENCE, 7 
actttggtat cgtggaagga ctcatgacca cagtccatgc catcactgcc 
<210> SEQ ID NO 8 
<211> LENGTH, 51 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, Description of Artificial Sequence, Synthetic 
target oligonucleotide 
<400> SEQUENCE, 8 
actttggtat cgtggaagga ctcattgacc acagtccatg ccatcactgc c 
<210> SEQ ID NO 9 
<211> LENGTH, 52 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, Description of Artificial Sequence, Synthetic 
target oligonucleotide 
42 
23 
23 
23 
49 
50 
51 
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-continued 
<400> SEQUENCE, 9 
actttggtat cgtggaagga ctcatttgac cacagtccat gccatcactg cc 
<210> SEQ ID NO 10 
<211> LENGTH, 60 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, Description of Artificial Sequence, Synthetic 
target oligonucleotide 
<400> SEQUENCE, 10 
52 
tgacaacttt ggtatcgtgg aaggactcat gaccacagtc catgccatca ctgccaccca 60 
<210> SEQ ID NO 11 
<211> LENGTH, 24 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, Description of Artificial Sequence, Synthetic 
oligonucleotide 
<400> SEQUENCE, 11 
gagtccttcc acgataccag actc 
<210> SEQ ID NO 12 
<211> LENGTH, 23 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, Description of Artificial Sequence, Synthetic 
oligonucleotide 
<400> SEQUENCE, 12 
ccacatgatg gcatggactg tgg 
<210> SEQ ID NO 13 
<211> LENGTH, 22 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, Description of Artificial Sequence, Probe 
<400> SEQUENCE, 13 
gagtccttcc acgataccac tc 
<210> SEQ ID NO 14 
<211> LENGTH, 24 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, Description of Artificial Sequence, Probe 
<400> SEQUENCE, 14 
gagtccttcc acgataccag actc 
<210> SEQ ID NO 15 
<211> LENGTH, 25 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, Description of Artificial Sequence, Probe 
<400> SEQUENCE, 15 
gagtccttcc acgataccag gactc 
24 
23 
22 
24 
25 
44 
<210> SEQ ID NO 16 
<211> LENGTH, 27 
<212> TYPE, DNA 
45 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
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<223> OTHER INFORMATION, Description of Artificial Sequence, Probe 
<400> SEQUENCE, 16 
cctcgagtcc ttccacgata ccagagg 
<210> SEQ ID NO 17 
<211> LENGTH, 29 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, Description of Artificial Sequence, Probe 
<400> SEQUENCE, 17 
ctgacgagtc cttccacgat accagtcag 
<210> SEQ ID NO 18 
<211> LENGTH, 30 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, Description of Artificial Sequence, Probe 
<400> SEQUENCE, 18 
ctgagcgagt ccttccacga taccagctca 
<210> SEQ ID NO 19 
<211> LENGTH, 27 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, Description of Artificial Sequence, Synthetic 
target oligonucleotide 
<400> SEQUENCE, 19 
actttggtat cgtggaagga ctcatga 
<210> SEQ ID NO 20 
<211> LENGTH, 27 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, Description of Artificial Sequence, Synthetic 
target oligonucleotide 
<400> SEQUENCE, 20 
actttggtat cgtggaagga atcatga 
<210> SEQ ID NO 21 
<211> LENGTH, 27 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, Description of Artificial Sequence, Synthetic 
target oligonucleotide 
<400> SEQUENCE, 21 
actttggtat cgtagaagga ctcatga 
<210> SEQ ID NO 22 
<211> LENGTH, 27 
<212> TYPE, DNA 
46 
27 
29 
30 
27 
27 
27 
47 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
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<223> OTHER INFORMATION, Description of Artificial Sequence, Synthetic 
target oligonucleotide 
<400> SEQUENCE, 22 
actttggtat cgtagaagga atcatga 
<210> SEQ ID NO 23 
<211> LENGTH, 27 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, Description of Artificial Sequence, Synthetic 
target oligonucleotide 
<400> SEQUENCE, 23 
actttggtat cgtaaaagga ctcatga 
<210> SEQ ID NO 24 
<211> LENGTH, 25 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, Description of Artificial Sequence, Synthetic 
oligonucleotide 
<400> SEQUENCE, 24 
gagtccttcc acgtaaccag gactc 
<210> SEQ ID NO 25 
<211> LENGTH, 27 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, Description of Artificial Sequence, Synthetic 
target oligonucleotide 
<400> SEQUENCE, 25 
actttggtat cgtggaagga ctcatga 
<210> SEQ ID NO 26 
<211> LENGTH, 22 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, Description of Artificial Sequence, Synthetic 
oligonucleotide 
<400> SEQUENCE, 26 
gagtccttcc acgataccac tc 
<210> SEQ ID NO 27 
<211> LENGTH, 78 
<212> TYPE, DNA 
<213> ORGANISM, Homo sapiens 
<400> SEQUENCE, 27 
27 
27 
25 
27 
22 
atgactgaat ataaacttgt ggtagttgga gctggtggcg taggcaagag tgccttgacg 60 
atacagctaa ttcagaat 78 
<210> SEQ ID NO 28 
<211> LENGTH, 24 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
48 
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-continued 
<223> OTHER INFORMATION, Description of Artificial Sequence, Synthetic 
oligonucleotide 
<400> SEQUENCE, 28 
agtgcgctgt atcgtcaagg cact 
<210> SEQ ID NO 29 
<211> LENGTH, 22 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, Description of Artificial Sequence, Synthetic 
oligonucleotide 
<400> SEQUENCE, 29 
cctacgccat cagctccgta gg 
<210> SEQ ID NO 30 
<211> LENGTH, 22 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, Description of Artificial Sequence, Synthetic 
oligonucleotide 
<400> SEQUENCE, 30 
cctacgccaa cagctccgta gg 
<210> SEQ ID NO 31 
<211> LENGTH, 22 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, Description of Artificial Sequence, Synthetic 
oligonucleotide 
<400> SEQUENCE, 31 
cctacgccac gagctccgta gg 
<210> SEQ ID NO 32 
<211> LENGTH, 22 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, Description of Artificial Sequence, Synthetic 
oligonucleotide 
<400> SEQUENCE, 32 
cctacgccac aagctccgta gg 
<210> SEQ ID NO 33 
<211> LENGTH, 121 
<212> TYPE, DNA 
<213> ORGANISM, Homo sapiens 
<400> SEQUENCE, 33 
24 
22 
22 
22 
22 
atgggtgccc cgacgttgcc ccctgcctgg cagccctttc tcaaggacca ccgcatctct 60 
acattcaaga actggccctt cttggagggc tgcgcctgca ccccggagcg gatggccgag 120 
g 121 
<210> SEQ ID NO 34 
<211> LENGTH, 23 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
50 
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-continued 
<223> OTHER INFORMATION, Description of Artificial Sequence, Synthetic 
oligonucleotide 
<400> SEQUENCE, 34 
ccttgagaaa gggctgccca agg 
<210> SEQ ID NO 35 
<211> LENGTH, 23 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
23 
<223> OTHER INFORMATION, Description of Artificial Sequence, Synthetic 
oligonucleotide 
<400> SEQUENCE, 35 
ccgcattgaa tgtagagatg egg 
<210> SEQ ID NO 36 
<211> LENGTH, 24 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
23 
<223> OTHER INFORMATION, Description of Artificial Sequence, Probe 
<400> SEQUENCE, 36 
acctggatgt tgtcctcgtc aggt 
<210> SEQ ID NO 37 
<211> LENGTH, 24 
<212> TYPE, DNA 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
24 
<223> OTHER INFORMATION, Description of Artificial Sequence, Probe 
<400> SEQUENCE, 37 
aagattgaag accttggcga tctt 
We claim: 
1. A composition comprising: 
(a) a stem-loop donor molecular beacon; and 
40 
24 
5. The compos1t10n of claim 1, wherein the acceptor 
molecular beacon comprises a resonance energy transfer 
acceptor moiety or a luminescence resonance energy transfer 
acceptor moiety. 
(b) a stem-loop acceptor molecular beacon, wherein reso-
45 
nance energy transfer occurs between the donor molecu-
6. The composition of claim 5, wherein the acceptor moiety 
comprises a fluorophore or a phycobiliprotein. 
lar beacon and the acceptor molecular beacon when the 
donor and acceptor molecular beacons hybridize adja-
cent to each other on a target nucleic acid and are 
exposed to an exciting amount of electromagnetic radia-
tion, and 
(c) means for delivering the stem-loop donor molecular 
beacon and the stem-loop donor molecular beacons into 
a cell. 
2. The composition of claim 1, wherein the donor molecu-
lar beacon comprises a resonance energy transfer donor moi-
ety or a luminescence resonance energy transfer donor moi-
ety. 
7. The composition of claim 1, wherein acceptor molecular 
beacon comprises a quencher that reduces emissions from the 
acceptor moiety when the acceptor molecular beacon is not 
50 hybridized to the target nucleic acid. 
8. The composition of claim 1, wherein emission from the 
acceptor molecular beacon produces a detectable signal 
resulting from resonance energy transfer. 
9. The composition of claim 1, wherein the energy to excite 
55 the donor molecular beacon has a negligible capacity to 
directly excite the acceptor molecular beacon. 
3. The composition of claim 2, wherein the donor molecu- 60 
10. The composition of claim 1, wherein unquenched 
emission from the donor moiety or acceptor moiety is distin-
guishable from emissions from the acceptor moiety resulting 
from resonance energy transfer. 
lar beacon comprises a quencher that reduces emissions from 
the donor moiety when the donor molecular beacon is not 
hybridized to the target nucleic acid. 
4. The composition of claim 2, wherein the donor moiety 65 
comprises a fluorophore, Europium, Terbium, or a lanthanide 
chelate. 
11. A composition comprising: 
(a) a shared-stem acceptor molecular beacon; and 
(b) a shared-stem donor molecular beacon, wherein fluo-
rescence resonance energy transfer occurs between the 
acceptor molecular beacon and the donor molecular bea-
con when the acceptor and donor molecular beacons 
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hybridize adjacent to each other on a target nucleic acid 
and are exposed to an exciting amount of electromag-
netic radiation. 
12. The composition of claim 11, wherein the donor 
molecular beacon comprises a resonance energy transfer 
donor moiety or a luminescence resonance energy transfer 
donor moiety. 
13. The composition of claim 12, wherein the donor 
molecular beacon comprises a quencher that reduces emis-
sions from the donor moiety when the donor molecular bea- 10 
con is not hybridized to the target nucleic acid. 
14. The composition of claim 12, wherein the donor moiety 
comprises a fluorophore, Europium, Terbium, or a lanthanide 
chelate. 
15. The composition of claim 11, wherein the acceptor 15 
molecular beacon comprises a resonance energy transfer 
acceptor moiety or a luminescence resonance energy transfer 
acceptor moiety. 
54 
(c) detecting emissions from the acceptor molecular bea-
con resulting from resonance energy transfer, wherein a 
detectable signal is indicative of cancer. 
25. The method of claim 24, wherein the cancer is pancre-
atic cancer. 
26. The method of claim 24, wherein the subject nucleic 
acid encodes an oncogene or tumor suppressor gene. 
27. The method of claim 26, wherein the oncogene or 
tumor suppressor gene is selected from the group consisting 
ofK-ras, p53, p16, MADH4, DPC4, BRCA2, MKK4, STK 
11, TGFBRl, and TGFBR2. 
28. The method of claim 24, wherein the subject nucleic 
acid can be used for the direct detection of an infectious 
disease agent or quantification of an infectious agent. 
29. The method of claim 24, wherein detectable emissions 
indicate the location the subject nucleic acid. 
30. The method of claim 24, wherein the molecular bea-
cons are shared-stem molecular beacons. 
16. The composition of claim 15, wherein the acceptor 
moiety comprises a fluorophore or a phycobiliprotein. 
17. The composition of claim 11, wherein acceptor 
molecular beacon comprises a quencher that reduces emis-
sions from the acceptor moiety when the acceptor molecular 
beacon is not hybridized to the target nucleic acid. 
31. A method for identifying compounds that increase or 
20 decrease expression of a subject nucleic acid comprising: 
(a) delivering stem-loop acceptor molecular beacons and a 
stem-loop donor molecular beacons to an interior of a 
cell suspected of being cancerous; 
18. The composition of claim 11, wherein emission from 25 
the acceptor molecular beacon produces a detectable signal. 
19. The composition of claim 11, wherein the energy to 
excite the donor molecular beacon has a negligible capacity to 
directly excite the acceptor molecular beacon. 
20. The composition of claim 11, wherein unquenched 30 
emission from the donor moiety or acceptor moiety is distin-
guishable from emissions from the acceptor moiety resulting 
from resonance energy transfer. 
21. A method for detecting expression of a target nucleic 
acid in a cell comprising: 
(a) delivering a stem-loop acceptor molecular beacon and a 
stem-loop donor molecular beacon to an interior of a 
cell; 
35 
(b) exposing the molecular beacons to an exciting amount 
of electromagnetic radiation so that fluorescence reso-
nance energy transfer occurs between the acceptor 
molecular beacons and the donor molecular beacons 
when the acceptor and donor molecular beacons hybrid-
ize adjacent to each other on the subject nucleic acid; 
( c) detecting a first signal from the acceptor molecular 
beacons resulting from resonance energy transfer; 
( d) contacting the cell comprising the molecular beacons 
with a test compound; 
( e) detecting a second signal from the acceptor molecular 
beacons resulting from resonance energy transfer, 
wherein in an increased second signal compared to the 
first signal indicates that the test compound increases 
expression of the target nucleic acid and a decreased 
second signal compared to the first signal indicates that 
the test compound decreases expression of the subject 
nucleic acid. 
32. The method of claim 31, wherein the subject nucleic 
acid encodes an oncogene or tumor suppressor gene. 
(b) exposing the molecular beacons with an exciting 
amount of electromagnetic energy so that fluorescence 40 
resonance energy transfer occurs between the acceptor 
molecular beacon and the donor molecular beacon when 
the acceptor and donor molecular beacons hybridize 
adjacent to each other on the target nucleic acid; and 
( c) detecting a signal resulting from fluorescence reso-
nance energy transfer between the stem-loop donor 
molecular beacon and the stem-loop acceptor molecular 
beacon in response to the exciting amount of electro-
magnetic energy wherein a detectable signal indicates 
the presence of the target nucleic acid. 
45 
33. The method of claim 31, wherein the molecular bea-
cons are shared-stem molecular beacons. 
22. The method of claim 21, wherein the target nucleic acid 
comprises RNA. 
23. The method of claim 21, wherein the molecular bea-
cons are shared-stem molecular beacons. 
24. A method for detecting cancer comprising: 
50 
55 
(a) delivering a stem-loop acceptor molecular beacon and a 
stem-loop donor molecular beacon to an interior of a cell 
suspected of being cancerous, wherein the molecular 
beacons specifically hybridize to a subject nucleic acid 
that is differentially expressed in cancer cells compared 60 
to non-cancer cells; 
(b) exposing the molecular beacons with an exciting 
amount of radiation so that fluorescence resonance 
energy transfer occurs between the acceptor molecular 
beacon and the donor molecular beacon when the accep- 65 
tor and donor molecular beacons hybridize adjacent to 
each other on the subject nucleic acid; and 
34. The method of claim 31, wherein the test compound 
comprises hormones or growth factors. 
35. A system for detecting a target nucleic acid comprising: 
(a) a stem-loop donor molecular beacon; 
(b) a stem-loop acceptor molecular beacon, wherein reso-
nance energy transfer occurs between the donor molecu-
lar beacon and the acceptor molecular beacon when the 
donor and acceptor molecular beacons hybridize adja-
cent to each other on a target nucleic acid and are 
exposed to an exciting amount of electromagnetic radia-
ti on; 
( c) means for exciting the molecular beacons; 
( d) means for detecting emissions from the molecular bea-
cons; and 
( e) means for delivering the beacons inside the cell. 
36. The system of claim 35, wherein the means for exciting 
the molecular beacons comprises a laser, a one-photon exci-
tation device, or a two-photon excitation device. 
37. A kit comprising: 
a) a stem-loop acceptor molecular beacon that specifically 
hybridizes to a target nucleic acid; 
US 7,399,591 B2 
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b) a stem-loop donor molecular beacon that specifically 
hybridizes to the target nucleic acid, 
wherein fluorescence resonance energy transfer occurs 
between the acceptor molecular beacon and the donor 
molecular beacon when the acceptor and donor molecu-
lar beacons hybridize adjacent to each other on a target 
nucleic acid and are exposed to an exciting amount of 
electromagnetic radiation; and 
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c) instructions for detecting the target nucleic acid using 
the molecular beacons. 
38. The kit of claim 37, wherein the molecular beacons are 
shared-stem molecular beacons. 
39. The kit of claim 37, further comprising a means for 
delivering the molecular beacons into a cell. 
* * * * * 
